Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:coumestrol
go back to main search page
Accession:CHEBI:3908 term browser browse the term
Definition:A member of the class of coumestans that is coumestan with hydroxy substituents at positions 3 and 9.
Synonyms:related_synonym: 3,9-Dihydroxy-6H-[1]benzofuro[3,2-c]chromen-6-one;   3,9-dihydroxycoumestan;   Chrysanthin;   Formula=C15H8O5;   InChI=1S/C15H8O5/c16-7-1-3-9-11(5-7)19-14-10-4-2-8(17)6-12(10)20-15(18)13(9)14/h1-6,16-17H;   InChIKey=ZZIALNLLNHEQPJ-UHFFFAOYSA-N;   SMILES=Oc1ccc2c(c1)oc1c3ccc(O)cc3oc(=O)c21
 xref: CAS:479-13-0;   HMDB:HMDB0002326;   KEGG:C10205;   KNApSAcK:C00002514;   LINCS:LSM-4202;   LIPID_MAPS_instance:LMPK12090018
 xref_mesh: MESH:D003375
 xref: MetaCyc:CPD-11779;   PMID:22644850;   PMID:22694330;   PMID:22824334;   PMID:22926873;   PMID:23348407;   Reaxys:266702;   Wikipedia:Coumestrol


show annotations for term's descendants           Sort by:
 
coumestrol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G 1700066M21Rik RIKEN cDNA 1700066M21 gene multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of C2ORF69 mRNA
Coumestrol results in increased expression of C2ORF69 mRNA
CTD PMID:19167446 NCBI chr 1:57,377,596...57,385,428
Ensembl chr 1:57,377,620...57,385,423
JBrowse link
G 1810037I17Rik RIKEN cDNA 1810037I17 gene decreases expression ISO Coumestrol results in decreased expression of C4ORF3 mRNA CTD PMID:19167446 NCBI chr 3:122,924,397...122,926,194
Ensembl chr 3:122,924,203...122,926,184
JBrowse link
G 2410002F23Rik RIKEN cDNA 2410002F23 gene increases expression ISO Coumestrol results in increased expression of C19ORF48 mRNA CTD PMID:19167446 NCBI chr 7:44,246,711...44,252,319
Ensembl chr 7:44,246,722...44,252,319
JBrowse link
G 2610507B11Rik RIKEN cDNA 2610507B11 gene multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIAA0100 mRNA CTD PMID:19167446 NCBI chr11:78,261,650...78,290,625
Ensembl chr11:78,261,752...78,290,623
JBrowse link
G 2700049A03Rik RIKEN cDNA 2700049A03 gene increases expression ISO Coumestrol results in increased expression of KIAA0586 mRNA CTD PMID:19167446 NCBI chr12:71,136,848...71,309,964
Ensembl chr12:71,136,848...71,243,303
JBrowse link
G 3830406C13Rik RIKEN cDNA 3830406C13 gene increases expression ISO Coumestrol results in increased expression of C3ORF14 mRNA CTD PMID:19167446 NCBI chr14:12,284,153...12,324,492
Ensembl chr14:12,284,173...12,303,231
Ensembl chr14:12,284,173...12,303,231
JBrowse link
G 4833420G17Rik RIKEN cDNA 4833420G17 gene increases expression
multiple interactions
ISO Coumestrol results in increased expression of C5ORF34 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C5ORF34 mRNA
CTD PMID:19167446 NCBI chr13:119,462,015...119,486,120
Ensembl chr13:119,462,768...119,486,120
JBrowse link
G 4833439L19Rik RIKEN cDNA 4833439L19 gene decreases expression ISO Coumestrol results in decreased expression of KIAA1191 mRNA CTD PMID:19167446 NCBI chr13:54,551,218...54,565,382
Ensembl chr13:54,551,218...54,565,435
JBrowse link
G 4930579G24Rik RIKEN cDNA 4930579G24 gene increases expression
multiple interactions
ISO Coumestrol results in increased expression of C4ORF46 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of C4ORF46 mRNA
CTD PMID:19167446 NCBI chr 3:79,629,079...79,632,820
Ensembl chr 3:79,629,079...79,632,820
JBrowse link
G 6430548M08Rik RIKEN cDNA 6430548M08 gene multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIAA0513 mRNA
Coumestrol results in decreased expression of KIAA0513 mRNA
CTD PMID:19167446 NCBI chr 8:120,114,152...120,165,307
Ensembl chr 8:120,114,152...120,165,306
JBrowse link
G Aaas achalasia, adrenocortical insufficiency, alacrimia multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AAAS mRNA
Coumestrol results in increased expression of AAAS mRNA
CTD PMID:19167446 NCBI chr15:102,338,247...102,350,759
Ensembl chr15:102,338,252...102,350,771
JBrowse link
G Aars alanyl-tRNA synthetase increases expression ISO Coumestrol results in increased expression of AARS1 mRNA CTD PMID:19167446 NCBI chr 8:111,027,778...111,055,569
Ensembl chr 8:111,033,144...111,057,664
JBrowse link
G Abat 4-aminobutyrate aminotransferase increases expression ISO Coumestrol results in increased expression of ABAT mRNA CTD PMID:19167446 NCBI chr16:8,513,429...8,621,568
Ensembl chr16:8,513,429...8,621,568
JBrowse link
G Abcc5 ATP-binding cassette, sub-family C (CFTR/MRP), member 5 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABCC5 mRNA CTD PMID:19167446 NCBI chr16:20,331,303...20,426,428
Ensembl chr16:20,331,303...20,426,394
JBrowse link
G Abcd3 ATP-binding cassette, sub-family D (ALD), member 3 decreases expression ISO Coumestrol results in decreased expression of ABCD3 mRNA CTD PMID:19167446 NCBI chr 3:121,758,904...121,815,302
Ensembl chr 3:121,758,774...121,815,302
JBrowse link
G Abce1 ATP-binding cassette, sub-family E (OABP), member 1 increases expression ISO Coumestrol results in increased expression of ABCE1 mRNA CTD PMID:19167446 NCBI chr 8:79,683,442...79,711,740
Ensembl chr 8:79,683,462...79,711,740
JBrowse link
G Abcf1 ATP-binding cassette, sub-family F (GCN20), member 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ABCF1 mRNA
Coumestrol results in increased expression of ABCF1 mRNA
CTD PMID:19167446 NCBI chr17:35,956,819...35,969,750
Ensembl chr17:35,956,819...35,969,761
JBrowse link
G Abcg1 ATP binding cassette subfamily G member 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABCG1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of ABCG1 mRNA CTD PMID:19167446 NCBI chr17:31,057,694...31,117,984
Ensembl chr17:31,057,675...31,117,988
JBrowse link
G Abhd11 abhydrolase domain containing 11 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of ABHD11 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABHD11 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of ABHD11 mRNA
CTD PMID:19167446 NCBI chr 5:135,009,152...135,012,175
Ensembl chr 5:135,009,152...135,012,175
JBrowse link
G Abhd12 abhydrolase domain containing 12 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ABHD12 mRNA CTD PMID:19167446 NCBI chr 2:150,832,493...150,904,779
Ensembl chr 2:150,832,493...150,904,741
JBrowse link
G Abhd16a abhydrolase domain containing 16A decreases expression ISO Coumestrol results in decreased expression of ABHD16A mRNA CTD PMID:19167446 NCBI chr17:35,089,234...35,102,987
Ensembl chr17:35,089,263...35,102,987
JBrowse link
G Abi1 abl-interactor 1 decreases expression ISO Coumestrol results in decreased expression of ABI1 mRNA CTD PMID:19167446 NCBI chr 2:22,940,073...23,040,241
Ensembl chr 2:22,940,073...23,040,241
JBrowse link
G Abraxas1 BRCA1 A complex subunit decreases expression ISO Coumestrol results in decreased expression of ABRAXAS1 mRNA CTD PMID:19167446 NCBI chr 5:100,804,802...100,845,864
Ensembl chr 5:100,805,192...100,820,965
JBrowse link
G Acaa2 acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase) multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACAA2 mRNA CTD PMID:19167446 NCBI chr18:74,779,212...74,806,207
Ensembl chr18:74,779,197...74,806,208
JBrowse link
G Acat2 acetyl-Coenzyme A acetyltransferase 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACAT2 mRNA
Coumestrol results in increased expression of ACAT2 mRNA
CTD PMID:19167446 NCBI chr17:12,943,042...12,960,725
Ensembl chr17:12,942,890...12,960,747
JBrowse link
G Acbd3 acyl-Coenzyme A binding domain containing 3 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACBD3 mRNA CTD PMID:19167446 NCBI chr 1:180,726,043...180,754,204
Ensembl chr 1:180,726,043...180,754,204
JBrowse link
G Ackr3 atypical chemokine receptor 3 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACKR3 mRNA CTD PMID:19167446 NCBI chr 1:90,203,980...90,215,724
Ensembl chr 1:90,203,980...90,216,751
JBrowse link
G Acly ATP citrate lyase multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACLY mRNA
Coumestrol results in increased expression of ACLY mRNA
CTD PMID:19167446 NCBI chr11:100,476,352...100,528,000
Ensembl chr11:100,476,353...100,528,000
JBrowse link
G Acot4 acyl-CoA thioesterase 4 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACOT4 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ACOT4 mRNA
Coumestrol results in increased expression of ACOT4 mRNA
CTD PMID:19167446 NCBI chr12:84,037,254...84,044,723
Ensembl chr12:84,038,379...84,048,601
JBrowse link
G Acot7 acyl-CoA thioesterase 7 increases expression
multiple interactions
ISO Coumestrol results in increased expression of ACOT7 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACOT7 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ACOT7 mRNA
CTD PMID:19167446 NCBI chr 4:152,178,100...152,271,855
Ensembl chr 4:152,178,134...152,271,855
JBrowse link
G Acsl3 acyl-CoA synthetase long-chain family member 3 decreases expression ISO Coumestrol results in decreased expression of ACSL3 mRNA CTD PMID:19167446 NCBI chr 1:78,657,825...78,707,743
Ensembl chr 1:78,657,825...78,707,743
JBrowse link
G Acss3 acyl-CoA synthetase short-chain family member 3 decreases expression ISO Coumestrol results in decreased expression of ACSS3 mRNA CTD PMID:19167446 NCBI chr10:106,933,514...107,123,761
Ensembl chr10:106,933,517...107,123,668
JBrowse link
G Acvr1 activin A receptor, type 1 decreases expression ISO Coumestrol results in decreased expression of ACVR1 mRNA CTD PMID:19167446 NCBI chr 2:58,446,438...58,566,828
Ensembl chr 2:58,388,644...58,567,157
JBrowse link
G Acyp1 acylphosphatase 1, erythrocyte (common) type increases expression
multiple interactions
ISO Coumestrol results in increased expression of ACYP1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACYP1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ACYP1 mRNA
CTD PMID:19167446 NCBI chr12:85,272,398...85,288,438
Ensembl chr12:85,272,398...85,288,438
JBrowse link
G Adat1 adenosine deaminase, tRNA-specific 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ADAT1 mRNA CTD PMID:19167446 NCBI chr 8:111,958,920...111,992,307
Ensembl chr 8:111,966,908...111,992,302
JBrowse link
G Add3 adducin 3 (gamma) multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ADD3 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ADD3 mRNA
Coumestrol results in increased expression of ADD3 mRNA
CTD PMID:19167446 NCBI chr19:53,140,443...53,247,326
Ensembl chr19:53,140,443...53,247,399
JBrowse link
G Adk adenosine kinase increases expression ISO Coumestrol results in increased expression of ADK mRNA CTD PMID:19167446 NCBI chr14:21,052,574...21,448,569
Ensembl chr14:21,052,574...21,448,569
JBrowse link
G Adra2a adrenergic receptor, alpha 2a multiple interactions ISO [Coumestrol co-treated with ESR1 protein] results in increased expression of ADRA2A mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ADRA2A mRNA] CTD PMID:18310284 NCBI chr19:54,045,259...54,048,982
Ensembl chr19:54,044,151...54,048,982
JBrowse link
G Afap1 actin filament associated protein 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AFAP1 mRNA CTD PMID:19167446 NCBI chr 5:35,893,319...36,003,923
Ensembl chr 5:35,893,319...36,003,923
JBrowse link
G Aff4 AF4/FMR2 family, member 4 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AFF4 mRNA
Coumestrol results in decreased expression of AFF4 mRNA
CTD PMID:19167446 NCBI chr11:53,350,640...53,421,830
Ensembl chr11:53,350,833...53,421,830
JBrowse link
G Afp alpha fetoprotein affects binding ISO Coumestrol binds to AFP protein CTD PMID:23013281, PMID:25349334 NCBI chr 5:90,490,714...90,508,907
Ensembl chr 5:90,490,737...90,508,907
JBrowse link
G Agap1 ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 decreases expression ISO Coumestrol results in decreased expression of AGAP1 mRNA CTD PMID:19167446 NCBI chr 1:89,454,811...89,895,282
Ensembl chr 1:89,454,806...89,897,617
JBrowse link
G Ago2 argonaute RISC catalytic subunit 2 decreases expression ISO Coumestrol results in decreased expression of AGO2 mRNA CTD PMID:19167446 NCBI chr15:73,101,625...73,184,947
Ensembl chr15:73,095,844...73,184,935
JBrowse link
G Agpat3 1-acylglycerol-3-phosphate O-acyltransferase 3 decreases expression ISO Coumestrol results in decreased expression of AGPAT3 mRNA CTD PMID:19167446 NCBI chr10:78,269,174...78,352,497
Ensembl chr10:78,269,178...78,352,489
JBrowse link
G Agr2 anterior gradient 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AGR2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of AGR2 mRNA
Coumestrol results in increased expression of AGR2 mRNA
CTD PMID:19167446 NCBI chr12:35,992,925...36,004,081
Ensembl chr12:35,992,907...36,004,087
JBrowse link
G Agr3 anterior gradient 3 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AGR3 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of AGR3 mRNA
Coumestrol results in increased expression of AGR3 mRNA
CTD PMID:19167446 NCBI chr12:35,925,621...35,949,737
Ensembl chr12:35,925,620...35,949,736
JBrowse link
G Agtrap angiotensin II, type I receptor-associated protein increases expression ISO Coumestrol results in increased expression of AGTRAP mRNA CTD PMID:19167446 NCBI chr 4:148,077,061...148,088,064
Ensembl chr 4:148,077,061...148,088,031
JBrowse link
G Ahcyl1 S-adenosylhomocysteine hydrolase-like 1 decreases expression ISO Coumestrol results in decreased expression of AHCYL1 mRNA CTD PMID:19167446 NCBI chr 3:107,663,120...107,696,560
Ensembl chr 3:107,663,118...107,696,560
JBrowse link
G Ahsa1 AHA1, activator of heat shock protein ATPase 1 increases expression ISO Coumestrol results in increased expression of AHSA1 mRNA CTD PMID:19167446 NCBI chr12:87,266,415...87,273,998
Ensembl chr12:87,266,479...87,273,998
JBrowse link
G Ajuba ajuba LIM protein multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AJUBA mRNA
Coumestrol results in decreased expression of AJUBA mRNA
CTD PMID:19167446 NCBI chr14:54,567,469...54,577,661
Ensembl chr14:54,567,472...54,577,558
JBrowse link
G Akap13 A kinase (PRKA) anchor protein 13 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of AKAP13 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AKAP13 mRNA
CTD PMID:19167446 NCBI chr 7:75,455,526...75,754,609
Ensembl chr 7:75,455,534...75,754,609
JBrowse link
G Alcam activated leukocyte cell adhesion molecule decreases expression ISO Coumestrol results in decreased expression of ALCAM mRNA CTD PMID:19167446 NCBI chr16:52,248,996...52,453,081
Ensembl chr16:52,248,996...52,454,074
JBrowse link
G Aldh16a1 aldehyde dehydrogenase 16 family, member A1 increases expression ISO Coumestrol results in increased expression of ALDH16A1 mRNA CTD PMID:19167446 NCBI chr 7:45,141,833...45,154,536
Ensembl chr 7:45,140,684...45,154,584
JBrowse link
G Aldh3b2 aldehyde dehydrogenase 3 family, member B2 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of ALDH3B2 mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of ALDH3B2 mRNA
CTD PMID:19167446 NCBI chr19:3,972,328...3,981,665
Ensembl chr19:3,972,328...3,981,646
JBrowse link
G Aldh4a1 aldehyde dehydrogenase 4 family, member A1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of ALDH4A1 mRNA CTD PMID:19167446 NCBI chr 4:139,622,871...139,649,691
Ensembl chr 4:139,622,866...139,649,690
JBrowse link
G Alg6 asparagine-linked glycosylation 6 (alpha-1,3,-glucosyltransferase) multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ALG6 mRNA
Coumestrol results in increased expression of ALG6 mRNA
CTD PMID:19167446 NCBI chr 4:99,715,596...99,763,460
Ensembl chr 4:99,715,664...99,763,460
JBrowse link
G Alg8 asparagine-linked glycosylation 8 (alpha-1,3-glucosyltransferase) increases expression
multiple interactions
ISO Coumestrol results in increased expression of ALG8 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ALG8 mRNA
CTD PMID:19167446 NCBI chr 7:97,371,567...97,392,159
Ensembl chr 7:97,371,606...97,392,185
JBrowse link
G Alkbh7 alkB homolog 7 decreases expression ISO Coumestrol results in decreased expression of ALKBH7 mRNA CTD PMID:19167446 NCBI chr17:56,997,339...56,999,340
Ensembl chr17:56,997,339...56,999,322
JBrowse link
G Alpl alkaline phosphatase, liver/bone/kidney multiple interactions ISO [Coumestrol binds to ESR1 protein] which results in increased activity of ALPL protein; fulvestrant inhibits the reaction [[Coumestrol binds to ESR1 protein] which results in increased activity of ALPL protein] CTD PMID:12650720 NCBI chr 4:137,741,731...137,796,384
Ensembl chr 4:137,741,733...137,796,384
JBrowse link
G Als2 alsin Rho guanine nucleotide exchange factor decreases expression ISO Coumestrol results in decreased expression of ALS2 mRNA CTD PMID:19167446 NCBI chr 1:59,162,756...59,237,231
Ensembl chr 1:59,162,926...59,237,231
JBrowse link
G Alyref Aly/REF export factor increases expression ISO Coumestrol results in increased expression of ALYREF mRNA CTD PMID:19167446 NCBI chr11:120,594,504...120,598,399
Ensembl chr11:120,592,121...120,598,365
JBrowse link
G Amd1 S-adenosylmethionine decarboxylase 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AMD1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of AMD1 mRNA
Coumestrol results in increased expression of AMD1 mRNA
CTD PMID:19167446 NCBI chr10:40,287,458...40,302,188
Ensembl chr10:40,287,458...40,302,188
JBrowse link
G Amfr autocrine motility factor receptor multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of AMFR mRNA CTD PMID:19167446 NCBI chr 8:93,971,588...94,012,640
Ensembl chr 8:93,971,588...94,012,842
JBrowse link
G Ammecr1 Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AMMECR1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of AMMECR1 mRNA
Coumestrol results in increased expression of AMMECR1 mRNA
CTD PMID:19167446 NCBI chr  X:142,851,146...142,966,726
Ensembl chr  X:142,851,146...142,966,728
JBrowse link
G Amotl2 angiomotin-like 2 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of AMOTL2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AMOTL2 mRNA
CTD PMID:19167446 NCBI chr 9:102,717,091...102,733,418
Ensembl chr 9:102,716,672...102,733,418
JBrowse link
G Anapc5 anaphase-promoting complex subunit 5 increases expression ISO Coumestrol results in increased expression of ANAPC5 mRNA CTD PMID:19167446 NCBI chr 5:122,787,459...122,822,339
Ensembl chr 5:122,787,459...122,821,339
JBrowse link
G Anapc7 anaphase promoting complex subunit 7 increases expression ISO Coumestrol results in increased expression of ANAPC7 mRNA CTD PMID:19167446 NCBI chr 5:122,422,444...122,444,912
Ensembl chr 5:122,421,693...122,444,912
JBrowse link
G Anln anillin, actin binding protein multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANLN mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of ANLN mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ANLN mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ANLN mRNA]
Coumestrol results in increased expression of ANLN mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr 9:22,331,214...22,389,211
Ensembl chr 9:22,332,012...22,389,188
JBrowse link
G Ano6 anoctamin 6 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANO6 mRNA
Coumestrol results in decreased expression of ANO6 mRNA
CTD PMID:19167446 NCBI chr15:95,790,843...95,975,472
Ensembl chr15:95,790,843...95,974,751
JBrowse link
G Anp32a acidic (leucine-rich) nuclear phosphoprotein 32 family, member A increases expression ISO Coumestrol results in increased expression of ANP32A mRNA CTD PMID:19167446 NCBI chr 9:62,341,343...62,378,804
Ensembl chr 9:62,341,293...62,378,812
JBrowse link
G Anp32e acidic (leucine-rich) nuclear phosphoprotein 32 family, member E multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANP32E mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of ANP32E mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ANP32E mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ANP32E mRNA]
Coumestrol results in increased expression of ANP32E mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr 3:95,929,245...95,947,387
Ensembl chr 3:95,929,246...95,947,390
JBrowse link
G Anxa2 annexin A2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA2 mRNA CTD PMID:19167446 NCBI chr 9:69,453,683...69,491,792
Ensembl chr 9:69,453,620...69,491,795
JBrowse link
G Anxa3 annexin A3 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA3 mRNA CTD PMID:19167446 NCBI chr 5:96,793,385...96,845,968
Ensembl chr 5:96,793,339...96,845,966
JBrowse link
G Anxa9 annexin A9 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANXA9 mRNA CTD PMID:19167446 NCBI chr 3:95,296,093...95,315,180
Ensembl chr 3:95,296,096...95,307,176
JBrowse link
G Ap1b1 adaptor protein complex AP-1, beta 1 subunit multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AP1B1 mRNA CTD PMID:19167446 NCBI chr11:4,947,320...5,042,794
Ensembl chr11:4,986,824...5,042,791
JBrowse link
G Ap1m1 adaptor-related protein complex AP-1, mu subunit 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AP1M1 mRNA CTD PMID:19167446 NCBI chr 8:72,240,013...72,257,386
Ensembl chr 8:72,240,018...72,257,385
JBrowse link
G Ap2s1 adaptor-related protein complex 2, sigma 1 subunit increases expression ISO Coumestrol results in increased expression of AP2S1 mRNA CTD PMID:19167446 NCBI chr 7:16,738,444...16,749,290
Ensembl chr 7:16,738,410...16,749,294
JBrowse link
G Apbb2 amyloid beta (A4) precursor protein-binding, family B, member 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of APBB2 mRNA CTD PMID:19167446 NCBI chr 5:66,298,725...66,619,064
Ensembl chr 5:66,298,703...66,618,784
JBrowse link
G Apod apolipoprotein D decreases expression ISO Coumestrol results in decreased expression of APOD mRNA CTD PMID:19167446 NCBI chr16:31,296,192...31,314,808
Ensembl chr16:31,296,192...31,314,808
JBrowse link
G App amyloid beta (A4) precursor protein decreases expression ISO Coumestrol results in decreased expression of APP mRNA CTD PMID:19167446 NCBI chr16:84,952,666...85,175,255
Ensembl chr16:84,949,685...85,173,766
JBrowse link
G Aqp3 aquaporin 3 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of AQP3 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AQP3 mRNA
CTD PMID:19167446 NCBI chr 4:41,092,724...41,098,183
Ensembl chr 4:41,092,722...41,098,183
JBrowse link
G Ar androgen receptor decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of AR mRNA
Coumestrol inhibits the reaction [Stanozolol binds to and results in increased activity of AR protein]
CTD PMID:11867264, PMID:29162470 NCBI chr  X:98,148,757...98,323,218
Ensembl chr  X:98,148,769...98,323,215
JBrowse link
G Arfgef2 ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited) decreases expression ISO Coumestrol results in decreased expression of ARFGEF2 mRNA CTD PMID:19167446 NCBI chr 2:166,805,451...166,898,052
Ensembl chr 2:166,805,588...166,898,052
JBrowse link
G Arfgef3 ARFGEF family member 3 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARFGEF3 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of ARFGEF3 mRNA
Coumestrol results in decreased expression of ARFGEF3 mRNA
CTD PMID:19167446 NCBI chr10:18,588,011...18,743,758
Ensembl chr10:18,581,839...18,743,949
JBrowse link
G Arhgap19 Rho GTPase activating protein 19 increases expression ISO Coumestrol results in increased expression of ARHGAP19 mRNA CTD PMID:19167446 NCBI chr19:41,766,588...41,802,084
Ensembl chr19:41,766,588...41,802,047
JBrowse link
G Arhgap39 Rho GTPase activating protein 39 decreases expression ISO Coumestrol results in decreased expression of ARHGAP39 mRNA CTD PMID:19167446 NCBI chr15:76,723,985...76,818,166
Ensembl chr15:76,723,985...76,818,170
JBrowse link
G Arhgdia Rho GDP dissociation inhibitor (GDI) alpha multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARHGDIA mRNA CTD PMID:19167446 NCBI chr11:120,578,099...120,581,624
Ensembl chr11:120,578,104...120,581,624
JBrowse link
G Arhgef26 Rho guanine nucleotide exchange factor (GEF) 26 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARHGEF26 mRNA
Coumestrol results in increased expression of ARHGEF26 mRNA
CTD PMID:19167446 NCBI chr 3:62,338,777...62,462,221
Ensembl chr 3:62,338,344...62,462,221
JBrowse link
G Arhgef37 Rho guanine nucleotide exchange factor (GEF) 37 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARHGEF37 mRNA CTD PMID:19167446 NCBI chr18:61,491,657...61,536,928
Ensembl chr18:61,491,657...61,536,594
JBrowse link
G Arhgef39 Rho guanine nucleotide exchange factor (GEF) 39 increases expression ISO Coumestrol results in increased expression of ARHGEF39 mRNA CTD PMID:19167446 NCBI chr 4:43,496,139...43,508,747
Ensembl chr 4:43,496,142...43,499,695
JBrowse link
G Arid4b AT rich interactive domain 4B (RBP1-like) decreases expression ISO Coumestrol results in decreased expression of ARID4B mRNA CTD PMID:19167446 NCBI chr13:14,063,609...14,199,603
Ensembl chr13:14,063,232...14,199,603
JBrowse link
G Arl3 ADP-ribosylation factor-like 3 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARL3 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ARL3 mRNA CTD PMID:19167446 NCBI chr19:46,531,109...46,573,182
Ensembl chr19:46,531,096...46,573,198
JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator decreases expression ISO Coumestrol results in decreased expression of ARNT mRNA CTD PMID:19167446 NCBI chr 3:95,434,367...95,497,240
Ensembl chr 3:95,434,388...95,497,240
JBrowse link
G Arrdc3 arrestin domain containing 3 decreases expression ISO Coumestrol results in decreased expression of ARRDC3 mRNA CTD PMID:19167446 NCBI chr13:80,883,384...80,896,042
Ensembl chr13:80,883,384...80,896,042
JBrowse link
G Arx aristaless related homeobox multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARX mRNA CTD PMID:19167446 NCBI chr  X:93,286,507...93,298,357
Ensembl chr  X:93,286,445...93,298,357
JBrowse link
G Asap1 ArfGAP with SH3 domain, ankyrin repeat and PH domain1 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of ASAP1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ASAP1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of ASAP1 mRNA
CTD PMID:19167446 NCBI chr15:64,086,840...64,382,941
Ensembl chr15:64,086,857...64,382,919
JBrowse link
G Asf1b anti-silencing function 1B histone chaperone increases expression
multiple interactions
ISO Coumestrol results in increased expression of ASF1B mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ASF1B mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ASF1B mRNA
CTD PMID:19167446 NCBI chr 8:83,955,694...83,970,195
Ensembl chr 8:83,955,507...83,970,197
JBrowse link
G Aspm abnormal spindle microtubule assembly multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ASPM mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of ASPM mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ASPM mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ASPM mRNA]
Coumestrol results in increased expression of ASPM mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr 1:139,454,188...139,494,088
Ensembl chr 1:139,454,772...139,494,091
JBrowse link
G Atad2 ATPase family, AAA domain containing 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATAD2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ATAD2 mRNA
Coumestrol results in increased expression of ATAD2 mRNA
CTD PMID:19167446 NCBI chr15:58,094,044...58,135,525
Ensembl chr15:58,094,044...58,135,082
JBrowse link
G Atf2 activating transcription factor 2 increases expression ISO Coumestrol results in increased expression of ATF2 mRNA CTD PMID:19167446 NCBI chr 2:73,816,509...73,892,677
Ensembl chr 2:73,816,509...73,892,639
JBrowse link
G Atf3 activating transcription factor 3 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATF3 mRNA
Coumestrol results in decreased expression of ATF3 mRNA
CTD PMID:19167446 NCBI chr 1:191,170,296...191,183,333
Ensembl chr 1:191,170,296...191,218,039
JBrowse link
G Atf5 activating transcription factor 5 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATF5 mRNA CTD PMID:19167446 NCBI chr 7:44,812,256...44,816,658
Ensembl chr 7:44,812,256...44,816,658
JBrowse link
G Atg14 autophagy related 14 decreases expression ISO Coumestrol results in decreased expression of ATG14 mRNA CTD PMID:19167446 NCBI chr14:47,540,893...47,568,434
Ensembl chr14:47,540,893...47,570,649
JBrowse link
G Atp1b1 ATPase, Na+/K+ transporting, beta 1 polypeptide multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP1B1 mRNA CTD PMID:19167446 NCBI chr 1:164,437,099...164,458,355
Ensembl chr 1:164,437,109...164,458,355
JBrowse link
G Atp23 ATP23 metallopeptidase and ATP synthase assembly factor homolog multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATP23 mRNA
Coumestrol results in increased expression of ATP23 mRNA
CTD PMID:19167446 NCBI chr10:126,867,829...126,902,024
Ensembl chr10:126,868,427...126,901,355
JBrowse link
G Atp2a3 ATPase, Ca++ transporting, ubiquitous multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of ATP2A3 mRNA CTD PMID:19167446 NCBI chr11:72,961,169...72,993,043
Ensembl chr11:72,961,169...72,993,044
JBrowse link
G Atp2b1 ATPase, Ca++ transporting, plasma membrane 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP2B1 mRNA
Coumestrol results in decreased expression of ATP2B1 mRNA
CTD PMID:19167446 NCBI chr10:98,914,630...99,026,143
Ensembl chr10:98,914,406...99,026,143
JBrowse link
G Atp2c1 ATPase, Ca++-sequestering multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP2C1 mRNA
Coumestrol results in decreased expression of ATP2C1 mRNA
CTD PMID:19167446 NCBI chr 9:105,411,362...105,521,257
Ensembl chr 9:105,403,539...105,527,319
JBrowse link
G Atp5g1 ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C1 (subunit 9) multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATP5MC1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ATP5MC1 mRNA
Coumestrol results in increased expression of ATP5MC1 mRNA
CTD PMID:19167446 NCBI chr11:96,072,793...96,075,694
Ensembl chr11:96,068,852...96,075,670
JBrowse link
G Atp6v0e ATPase, H+ transporting, lysosomal V0 subunit E multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP6V0E1 mRNA
Coumestrol results in decreased expression of ATP6V0E1 mRNA
CTD PMID:19167446 NCBI chr17:26,676,396...26,699,647
Ensembl chr17:26,663,231...26,699,647
JBrowse link
G Atp8b1 ATPase, class I, type 8B, member 1 decreases expression ISO Coumestrol results in decreased expression of ATP8B1 mRNA CTD PMID:19167446 NCBI chr18:64,528,979...64,661,272
Ensembl chr18:64,528,967...64,661,267
JBrowse link
G Atp8b2 ATPase, class I, type 8B, member 2 multiple interactions
decreases expression
ISO [Coumestrol co-treated with resveratrol] results in decreased expression of ATP8B2 mRNA
Coumestrol results in decreased expression of ATP8B2 mRNA
CTD PMID:19167446 NCBI chr 3:89,939,481...89,963,338
Ensembl chr 3:89,939,481...89,963,508
JBrowse link
G Atp9a ATPase, class II, type 9A decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of ATP9A mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP9A mRNA
CTD PMID:19167446 NCBI chr 2:168,634,438...168,742,370
Ensembl chr 2:168,634,438...168,742,409
JBrowse link
G Atxn1 ataxin 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATXN1 mRNA CTD PMID:19167446 NCBI chr13:45,549,755...45,964,991
Ensembl chr13:45,549,755...45,965,008
JBrowse link
G Aurka aurora kinase A multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AURKA mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of AURKA mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of AURKA mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of AURKA mRNA]
Coumestrol results in increased expression of AURKA mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr 2:172,356,190...172,370,886
Ensembl chr 2:172,356,190...172,370,535
JBrowse link
G Aurkb aurora kinase B multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AURKB mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of AURKB mRNA
Coumestrol results in increased expression of AURKB mRNA
CTD PMID:19167446 NCBI chr11:69,045,624...69,051,664
Ensembl chr11:69,045,647...69,051,664
JBrowse link
G Auts2 autism susceptibility candidate 2 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of AUTS2 mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of AUTS2 mRNA
CTD PMID:19167446 NCBI chr 5:131,437,333...132,543,220
Ensembl chr 5:131,437,333...132,543,344
JBrowse link
G B2m beta-2 microglobulin increases expression ISO Coumestrol results in increased expression of B2M mRNA CTD PMID:19167446 NCBI chr 2:122,147,687...122,153,082
Ensembl chr 2:122,147,686...122,153,083
JBrowse link
G B3galnt1 UDP-GalNAc:betaGlcNAc beta 1,3-galactosaminyltransferase, polypeptide 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of B3GALNT1 mRNA CTD PMID:19167446 NCBI chr 3:69,573,919...69,598,960
Ensembl chr 3:69,574,158...69,598,960
JBrowse link
G B3gnt5 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of B3GNT5 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of B3GNT5 mRNA
Coumestrol results in decreased expression of B3GNT5 mRNA
CTD PMID:19167446 NCBI chr16:19,760,192...19,772,760
Ensembl chr16:19,760,208...19,772,753
JBrowse link
G Bace1 beta-site APP cleaving enzyme 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BACE1 mRNA CTD PMID:19167446 NCBI chr 9:45,838,545...45,862,484
Ensembl chr 9:45,838,580...45,864,399
JBrowse link
G Bace2 beta-site APP-cleaving enzyme 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BACE2 mRNA CTD PMID:19167446 NCBI chr16:97,356,728...97,442,936
Ensembl chr16:97,356,742...97,442,936
JBrowse link
G Bag2 BCL2-associated athanogene 2 increases expression
multiple interactions
ISO Coumestrol results in increased expression of BAG2 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of BAG2 mRNA
CTD PMID:19167446 NCBI chr 1:33,745,484...33,757,750
Ensembl chr 1:33,745,484...33,757,795
JBrowse link
G Bag3 BCL2-associated athanogene 3 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BAG3 mRNA
Coumestrol results in decreased expression of BAG3 mRNA
CTD PMID:19167446 NCBI chr 7:128,523,583...128,546,981
Ensembl chr 7:128,523,616...128,546,981
JBrowse link
G Bag5 BCL2-associated athanogene 5 decreases expression ISO Coumestrol results in decreased expression of BAG5 mRNA CTD PMID:19167446 NCBI chr12:111,709,488...111,713,256
Ensembl chr12:111,709,488...111,713,257
JBrowse link
G Banf1 BAF nuclear assembly factor 1 increases expression ISO Coumestrol results in increased expression of BANF1 mRNA CTD PMID:19167446 NCBI chr19:5,364,633...5,366,876
Ensembl chr19:5,364,638...5,367,168
JBrowse link
G Bard1 BRCA1 associated RING domain 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BARD1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of BARD1 mRNA
Coumestrol results in increased expression of BARD1 mRNA
CTD PMID:19167446 NCBI chr 1:71,027,535...71,103,141
Ensembl chr 1:71,027,498...71,103,146
JBrowse link
G Bax BCL2-associated X protein increases expression
affects binding
ISO Coumestrol results in increased expression of BAX protein
Coumestrol binds to BAX protein
CTD PMID:28986287 NCBI chr 7:45,461,695...45,466,903
Ensembl chr 7:45,461,697...45,466,898
JBrowse link
G Baz2a bromodomain adjacent to zinc finger domain, 2A decreases expression ISO Coumestrol results in decreased expression of BAZ2A mRNA CTD PMID:19167446 NCBI chr10:128,091,370...128,129,303
Ensembl chr10:128,091,577...128,129,303
JBrowse link
G Bbs1 Bardet-Biedl syndrome 1 (human) multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of BBS1 mRNA CTD PMID:19167446 NCBI chr19:4,886,878...4,906,653
Ensembl chr19:4,886,878...4,906,628
JBrowse link
G BC016579 cDNA sequence, BC016579 decreases expression ISO Coumestrol results in decreased expression of C3ORF52 mRNA CTD PMID:19167446 NCBI chr16:45,626,848...45,655,852
Ensembl chr16:45,626,848...45,654,068
JBrowse link
G BC031181 cDNA sequence BC031181 decreases expression ISO Coumestrol results in decreased expression of C18ORF32 mRNA CTD PMID:19167446 NCBI chr18:75,005,839...75,009,935
Ensembl chr18:75,005,868...75,010,152
JBrowse link
G BC055324 cDNA sequence BC055324 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C1ORF112 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of C1ORF112 mRNA
Coumestrol results in increased expression of C1ORF112 mRNA
CTD PMID:19167446 NCBI chr 1:163,945,993...163,994,809
Ensembl chr 1:163,945,993...163,994,796
JBrowse link
G Bcas3 breast carcinoma amplified sequence 3 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of BCAS3 mRNA CTD PMID:19167446 NCBI chr11:85,353,110...85,826,058
Ensembl chr11:85,353,167...85,826,058
JBrowse link
G Bckdhb branched chain ketoacid dehydrogenase E1, beta polypeptide decreases expression ISO Coumestrol results in decreased expression of BCKDHB mRNA CTD PMID:19167446 NCBI chr 9:83,925,111...84,124,240
Ensembl chr 9:83,925,145...84,124,240
JBrowse link
G Bcl2 B cell leukemia/lymphoma 2 decreases expression
affects binding
multiple interactions
ISO Coumestrol results in decreased expression of BCL2 protein
Coumestrol binds to BCL2 protein
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BCL2 mRNA
CTD PMID:19167446, PMID:20623010, PMID:28986287 NCBI chr 1:106,538,176...106,714,290
Ensembl chr 1:106,538,178...106,714,274
JBrowse link
G Bcl2l12 BCL2-like 12 (proline rich) multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BCL2L12 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of BCL2L12 mRNA
Coumestrol results in increased expression of BCL2L12 mRNA
CTD PMID:19167446 NCBI chr 7:44,991,222...44,997,638
Ensembl chr 7:44,991,222...44,998,712
JBrowse link
G Bcl3 B cell leukemia/lymphoma 3 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCL3 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of BCL3 mRNA CTD PMID:19167446 NCBI chr 7:19,808,462...19,822,824
Ensembl chr 7:19,808,462...19,822,770
JBrowse link
G Bcl9 B cell CLL/lymphoma 9 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCL9 mRNA CTD PMID:19167446 NCBI chr 3:97,203,658...97,298,402
Ensembl chr 3:97,203,662...97,297,917
JBrowse link
G Bcl9l B cell CLL/lymphoma 9-like decreases expression ISO Coumestrol results in decreased expression of BCL9L mRNA CTD PMID:19167446 NCBI chr 9:44,482,738...44,511,906
Ensembl chr 9:44,482,825...44,511,896
JBrowse link
G Bclaf1 BCL2-associated transcription factor 1 increases expression ISO Coumestrol results in increased expression of BCLAF1 mRNA CTD PMID:19167446 NCBI chr10:20,310,512...20,342,644
Ensembl chr10:20,312,469...20,344,613
JBrowse link
G Bclaf3 Bclaf1 and Thrap3 family member 3 decreases expression ISO Coumestrol results in decreased expression of BCLAF3 mRNA CTD PMID:19167446 NCBI chr  X:159,532,642...159,593,081
Ensembl chr  X:159,526,688...159,593,081
JBrowse link
G Bcs1l BCS1-like (yeast) increases expression ISO Coumestrol results in increased expression of BCS1L mRNA CTD PMID:19167446 NCBI chr 1:74,588,289...74,592,443
Ensembl chr 1:74,588,289...74,592,443
JBrowse link
G Bhlhe40 basic helix-loop-helix family, member e40 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BHLHE40 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of BHLHE40 mRNA
Coumestrol results in decreased expression of BHLHE40 mRNA
CTD PMID:19167446 NCBI chr 6:108,660,629...108,666,925
Ensembl chr 6:108,660,629...108,666,925
JBrowse link
G Bik BCL2-interacting killer multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of BIK mRNA CTD PMID:19167446 NCBI chr15:83,526,790...83,544,635
Ensembl chr15:83,526,862...83,544,634
JBrowse link
G Bin3 bridging integrator 3 multiple interactions ISO [Coumestrol co-treated with ESR1 protein] results in increased expression of BIN3 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of BIN3 mRNA] CTD PMID:18310284 NCBI chr14:70,100,089...70,137,964
Ensembl chr14:70,100,105...70,138,206
JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BIRC5 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of BIRC5 mRNA
Coumestrol results in increased expression of BIRC5 mRNA
CTD PMID:19167446 NCBI chr11:117,849,237...117,855,743
Ensembl chr11:117,849,251...117,855,743
JBrowse link
G Blm Bloom syndrome, RecQ like helicase multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BLM mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of BLM mRNA
Coumestrol results in increased expression of BLM mRNA
CTD PMID:19167446 NCBI chr 7:80,454,993...80,535,148
Ensembl chr 7:80,454,733...80,535,119
JBrowse link
G Blnk B cell linker multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BLNK mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of BLNK mRNA CTD PMID:19167446 NCBI chr19:40,928,927...40,994,221
Ensembl chr19:40,928,927...40,994,535
JBrowse link
G Bloc1s6 biogenesis of lysosomal organelles complex-1, subunit 6, pallidin decreases expression ISO Coumestrol results in decreased expression of BLOC1S6 mRNA CTD PMID:19167446 NCBI chr 2:122,738,505...122,749,487
Ensembl chr 2:122,738,503...122,749,475
JBrowse link
G Blvrb biliverdin reductase B (flavin reductase (NADPH)) increases expression ISO Coumestrol results in increased expression of BLVRB mRNA CTD PMID:19167446 NCBI chr 7:27,447,978...27,465,981
Ensembl chr 7:27,447,978...27,466,144
JBrowse link
G Blzf1 basic leucine zipper nuclear factor 1 decreases expression ISO Coumestrol results in decreased expression of BLZF1 mRNA CTD PMID:19167446 NCBI chr 1:164,289,799...164,307,487
Ensembl chr 1:164,289,800...164,307,489
JBrowse link
G Bmerb1 bMERB domain containing 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMERB1 mRNA; [Coumestrol co-treated with Resveratrol] results in decreased expression of BMERB1 mRNA
Coumestrol results in decreased expression of BMERB1 mRNA
CTD PMID:19167446 NCBI chr16:13,986,612...14,105,052
Ensembl chr16:13,986,604...14,101,500
JBrowse link
G Bmf BCL2 modifying factor multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMF mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of BMF mRNA
Coumestrol results in decreased expression of BMF mRNA
CTD PMID:19167446 NCBI chr 2:118,528,757...118,549,686
Ensembl chr 2:118,528,757...118,549,687
JBrowse link
G Bmp5 bone morphogenetic protein 5 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of BMP5 mRNA CTD PMID:19167446 NCBI chr 9:75,775,365...75,900,316
Ensembl chr 9:75,775,364...75,900,310
JBrowse link
G Bmp7 bone morphogenetic protein 7 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMP7 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of BMP7 mRNA
Coumestrol results in decreased expression of BMP7 mRNA
CTD PMID:19167446 NCBI chr 2:172,868,012...172,940,321
Ensembl chr 2:172,868,012...172,940,321
JBrowse link
G Bmpr2 bone morphogenetic protein receptor, type II (serine/threonine kinase) multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMPR2 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of BMPR2 mRNA CTD PMID:19167446 NCBI chr 1:59,764,279...59,878,081
Ensembl chr 1:59,763,400...59,879,014
JBrowse link
G Bnip3l BCL2/adenovirus E1B interacting protein 3-like decreases expression ISO Coumestrol results in decreased expression of BNIP3L mRNA CTD PMID:19167446 NCBI chr14:66,985,238...67,008,877
Ensembl chr14:66,985,239...67,008,877
JBrowse link
G Bora bora, aurora kinase A activator increases expression
multiple interactions
ISO Coumestrol results in increased expression of BORA mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of BORA mRNA
CTD PMID:19167446 NCBI chr14:99,046,377...99,074,540
Ensembl chr14:99,046,222...99,074,540
JBrowse link
G Brat1 BRCA1-associated ATM activator 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRAT1 mRNA CTD PMID:19167446 NCBI chr 5:140,704,763...140,719,379
Ensembl chr 5:140,705,011...140,719,379
JBrowse link
G Brca1 breast cancer 1, early onset multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRCA1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of BRCA1 mRNA
Coumestrol results in increased expression of BRCA1 mRNA
CTD PMID:19167446 NCBI chr11:101,488,761...101,551,955
Ensembl chr11:101,488,764...101,551,955
JBrowse link
G Brca2 breast cancer 2, early onset multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRCA2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of BRCA2 mRNA
Coumestrol results in increased expression of BRCA2 mRNA
CTD PMID:19167446 NCBI chr 5:150,522,297...150,570,147
Ensembl chr 5:150,522,630...150,570,329
JBrowse link
G Brd3 bromodomain containing 3 decreases expression ISO Coumestrol results in decreased expression of BRD3 mRNA CTD PMID:19167446 NCBI chr 2:27,445,576...27,507,657
Ensembl chr 2:27,445,579...27,507,662
JBrowse link
G Bri3 brain protein I3 decreases expression ISO Coumestrol results in decreased expression of BRI3 mRNA CTD PMID:19167446 NCBI chr 5:144,244,437...144,264,573
Ensembl chr 5:144,244,437...144,446,757
JBrowse link
G Bri3bp Bri3 binding protein multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRI3BP mRNA CTD PMID:19167446 NCBI chr 5:125,441,568...125,460,885
Ensembl chr 5:125,441,568...125,460,370
JBrowse link
G Brwd1 bromodomain and WD repeat domain containing 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BRWD1 mRNA CTD PMID:19167446 NCBI chr16:95,992,089...96,082,703
Ensembl chr16:95,992,092...96,082,526
JBrowse link
G Bsdc1 BSD domain containing 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BSDC1 mRNA CTD PMID:19167446 NCBI chr 4:129,461,679...129,488,498
Ensembl chr 4:129,461,581...129,488,498
JBrowse link
G Bsg basigin multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BSG mRNA CTD PMID:19167446 NCBI chr10:79,704,358...79,711,979
Ensembl chr10:79,704,491...79,711,969
JBrowse link
G Btbd7 BTB (POZ) domain containing 7 decreases expression ISO Coumestrol results in decreased expression of BTBD7 mRNA CTD PMID:19167446 NCBI chr12:102,780,797...102,878,471
Ensembl chr12:102,780,797...102,878,471
JBrowse link
G Btg1 BTG anti-proliferation factor 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BTG1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of BTG1 mRNA
Coumestrol results in decreased expression of BTG1 mRNA
CTD PMID:19167446 NCBI chr10:96,617,001...96,622,813
Ensembl chr10:96,617,006...96,622,809
JBrowse link
G Btg2 BTG anti-proliferation factor 2 multiple interactions
decreases expression
ISO [Coumestrol co-treated with resveratrol] results in decreased expression of BTG2 mRNA
Coumestrol results in decreased expression of BTG2 mRNA
CTD PMID:19167446 NCBI chr 1:134,074,865...134,079,155
Ensembl chr 1:134,075,170...134,079,120
JBrowse link
G Bub1 BUB1, mitotic checkpoint serine/threonine kinase increases expression
multiple interactions
ISO Coumestrol results in increased expression of BUB1 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of BUB1 mRNA
CTD PMID:19167446 NCBI chr 2:127,800,197...127,831,859
Ensembl chr 2:127,801,122...127,831,865
JBrowse link
G Bub1b BUB1B, mitotic checkpoint serine/threonine kinase multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BUB1B mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of BUB1B mRNA
Coumestrol results in increased expression of BUB1B mRNA
CTD PMID:19167446 NCBI chr 2:118,598,202...118,641,592
Ensembl chr 2:118,598,211...118,641,591
JBrowse link
G C130074G19Rik RIKEN cDNA C130074G19 gene multiple interactions
decreases expression
ISO [Coumestrol co-treated with resveratrol] results in decreased expression of C1ORF115 mRNA
Coumestrol results in decreased expression of C1ORF115 mRNA
CTD PMID:19167446 NCBI chr 1:184,871,926...184,883,036
Ensembl chr 1:184,871,926...184,883,218
JBrowse link
G Cacybp calcyclin binding protein increases expression
multiple interactions
ISO Coumestrol results in increased expression of CACYBP mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of CACYBP mRNA
CTD PMID:19167446 NCBI chr 1:160,202,367...160,212,892
Ensembl chr 1:160,202,367...160,212,875
JBrowse link
G Cadm1 cell adhesion molecule 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CADM1 mRNA
Coumestrol results in decreased expression of CADM1 mRNA
CTD PMID:19167446 NCBI chr 9:47,530,170...47,862,280
Ensembl chr 9:47,530,173...47,857,637
Ensembl chr 9:47,530,173...47,857,637
JBrowse link
G Calcr calcitonin receptor multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CALCR mRNA CTD PMID:19167446 NCBI chr 6:3,685,678...3,764,713
Ensembl chr 6:3,685,680...3,764,714
JBrowse link
G Calm3 calmodulin 3 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CALM3 mRNA CTD PMID:19167446 NCBI chr 7:16,915,379...16,924,032
Ensembl chr 7:16,915,379...16,924,114
JBrowse link
G Calu calumenin multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CALU mRNA
Coumestrol results in increased expression of CALU mRNA
CTD PMID:19167446 NCBI chr 6:29,348,106...29,376,675
Ensembl chr 6:29,348,069...29,377,110
JBrowse link
G Camk1d calcium/calmodulin-dependent protein kinase ID decreases expression ISO Coumestrol results in decreased expression of CAMK1D mRNA CTD PMID:19167446 NCBI chr 2:5,293,457...5,714,860
Ensembl chr 2:5,293,457...5,714,515
JBrowse link
G Camk2d calcium/calmodulin-dependent protein kinase II, delta decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CAMK2D mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAMK2D mRNA
CTD PMID:19167446 NCBI chr 3:126,595,487...126,846,326
Ensembl chr 3:126,596,302...126,846,326
JBrowse link
G Camk2n1 calcium/calmodulin-dependent protein kinase II inhibitor 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAMK2N1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of CAMK2N1 mRNA
Coumestrol results in decreased expression of CAMK2N1 mRNA
CTD PMID:19167446 NCBI chr 4:138,455,148...138,460,126
Ensembl chr 4:138,454,314...138,460,123
JBrowse link
G Cant1 calcium activated nucleotidase 1 increases expression ISO Coumestrol results in increased expression of CANT1 mRNA CTD PMID:19167446 NCBI chr11:118,406,289...118,419,134
Ensembl chr11:118,406,289...118,419,086
JBrowse link
G Car12 carbonic anhydrase 12 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CA12 mRNA CTD PMID:19167446 NCBI chr 9:66,712,296...66,766,845
Ensembl chr 9:66,713,686...66,766,845
JBrowse link
G Car2 carbonic anhydrase 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CA2 mRNA CTD PMID:19167446 NCBI chr 3:14,886,269...14,900,770
Ensembl chr 3:14,886,273...14,900,770
JBrowse link
G Carhsp1 calcium regulated heat stable protein 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CARHSP1 mRNA
Coumestrol results in increased expression of CARHSP1 mRNA
CTD PMID:19167446 NCBI chr16:8,658,580...8,672,153
Ensembl chr16:8,658,580...8,672,155
JBrowse link
G Casp3 caspase 3 increases expression ISO Coumestrol results in increased expression of CASP3 protein CTD PMID:19165469, PMID:28986287 NCBI chr 8:46,617,291...46,639,698
Ensembl chr 8:46,617,291...46,639,689
JBrowse link
G Casp7 caspase 7 increases expression ISO Coumestrol results in increased expression of CASP7 protein CTD PMID:19165469 NCBI chr19:56,396,833...56,442,348
Ensembl chr19:56,397,129...56,442,344
JBrowse link
G Casp8ap2 caspase 8 associated protein 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CASP8AP2 mRNA CTD PMID:19167446 NCBI chr 4:32,615,470...32,653,271
Ensembl chr 4:32,615,451...32,653,265
JBrowse link
G Casp9 caspase 9 increases expression ISO Coumestrol results in increased expression of CASP9 protein CTD PMID:28986287 NCBI chr 4:141,793,612...141,815,978
Ensembl chr 4:141,793,612...141,815,976
JBrowse link
G Cast calpastatin multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAST mRNA CTD PMID:19167446 NCBI chr13:74,692,366...74,808,874
Ensembl chr13:74,692,368...74,808,810
JBrowse link
G Cav1 caveolin 1, caveolae protein multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of CAV1 mRNA
Coumestrol results in increased expression of CAV1 mRNA
CTD PMID:19167446 NCBI chr 6:17,306,335...17,341,328
Ensembl chr 6:17,306,335...17,341,452
JBrowse link
G Cbfb core binding factor beta multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CBFB mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CBFB mRNA
Coumestrol results in increased expression of CBFB mRNA
CTD PMID:19167446 NCBI chr 8:105,170,674...105,217,989
Ensembl chr 8:105,170,674...105,217,989
JBrowse link
G Cblb Casitas B-lineage lymphoma b decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CBLB mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CBLB mRNA
CTD PMID:19167446 NCBI chr16:52,031,230...52,208,047
Ensembl chr16:52,031,225...52,208,048
JBrowse link
G Cbr1 carbonyl reductase 1 increases expression ISO Coumestrol results in increased expression of CBR1 mRNA CTD PMID:19167446 NCBI chr16:93,607,837...93,610,349
Ensembl chr16:93,605,853...93,610,505
JBrowse link
G Cbx4 chromobox 4 decreases expression ISO Coumestrol results in decreased expression of CBX4 mRNA CTD PMID:19167446 NCBI chr11:119,077,571...119,086,237
Ensembl chr11:119,077,573...119,086,221
JBrowse link
G Cbx5 chromobox 5 multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of CBX5 mRNA
Coumestrol results in increased expression of CBX5 mRNA
CTD PMID:19167446 NCBI chr15:103,191,546...103,239,904
Ensembl chr15:103,191,544...103,239,816
JBrowse link
G Ccdc117 coiled-coil domain containing 117 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CCDC117 mRNA CTD PMID:19167446 NCBI chr11:5,528,887...5,542,217
Ensembl chr11:5,528,887...5,542,187
JBrowse link
G Ccdc14 coiled-coil domain containing 14 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCDC14 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CCDC14 mRNA CTD PMID:19167446 NCBI chr16:34,690,557...34,725,204
Ensembl chr16:34,690,616...34,725,202
JBrowse link
G Ccdc167 coiled-coil domain containing 167 increases expression ISO Coumestrol results in increased expression of CCDC167 mRNA CTD PMID:19167446 NCBI chr17:29,695,977...29,717,041
Ensembl chr17:29,687,357...29,717,044
JBrowse link
G Ccdc34 coiled-coil domain containing 34 increases expression
multiple interactions
ISO Coumestrol results in increased expression of CCDC34 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCDC34 mRNA
CTD PMID:19167446 NCBI chr 2:110,017,499...110,175,662
Ensembl chr 2:110,017,817...110,173,360
JBrowse link
G Ccdc47 coiled-coil domain containing 47 increases expression ISO Coumestrol results in increased expression of CCDC47 mRNA CTD PMID:19167446 NCBI chr11:106,199,260...106,216,523
Ensembl chr11:106,197,408...106,216,344
JBrowse link
G Ccdc51 coiled-coil domain containing 51 increases expression ISO Coumestrol results in increased expression of CCDC51 mRNA CTD PMID:19167446 NCBI chr 9:109,082,496...109,093,363
Ensembl chr 9:109,082,493...109,092,489
JBrowse link
G Ccdc58 coiled-coil domain containing 58 increases expression ISO Coumestrol results in increased expression of CCDC58 mRNA CTD PMID:19167446 NCBI chr16:36,071,660...36,092,118
Ensembl chr16:36,071,685...36,092,120
JBrowse link
G Ccdc88c coiled-coil domain containing 88C decreases expression ISO Coumestrol results in decreased expression of CCDC88C mRNA CTD PMID:19167446 NCBI chr12:100,911,519...101,029,351
Ensembl chr12:100,911,523...101,029,056
JBrowse link
G Ccn1 cellular communication network factor 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CCN1 mRNA CTD PMID:19167446 NCBI chr 3:145,646,971...145,649,985
Ensembl chr 3:145,646,976...145,649,981
JBrowse link
G Ccn5 cellular communication network factor 5 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCN5 mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of CCN5 mRNA; ESR1 protein inhibits the reaction [Coumestrol results in increased expression of CCN5 mRNA] CTD PMID:19167446, PMID:23384675 NCBI chr 2:163,820,752...163,833,146
Ensembl chr 2:163,820,861...163,833,146
JBrowse link
G Ccna2 cyclin A2 decreases expression
increases expression
multiple interactions
ISO Coumestrol results in decreased expression of CCNA2 protein
Coumestrol results in increased expression of CCNA2 protein
[Coumestrol co-treated with ESR1 protein] results in increased expression of CCNA2 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CCNA2 mRNA]
CTD PMID:18310284, PMID:20623010 NCBI chr 3:36,564,865...36,573,038
Ensembl chr 3:36,564,865...36,572,150
JBrowse link
G Ccnb1 cyclin B1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNB1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CCNB1 mRNA
Coumestrol results in increased expression of CCNB1 mRNA
CTD PMID:19167446 NCBI chr13:100,778,739...100,786,486
Ensembl chr13:100,778,650...100,786,570
JBrowse link
G Ccnb2 cyclin B2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNB2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CCNB2 mRNA
Coumestrol results in increased expression of CCNB2 mRNA
CTD PMID:19167446 NCBI chr 9:70,407,689...70,421,554
Ensembl chr 9:70,407,692...70,421,547
JBrowse link
G Ccnd1 cyclin D1 multiple interactions
increases expression
ISO CCND1 protein promotes the reaction [Coumestrol results in increased activity of ESR1 protein]
Coumestrol results in increased expression of CCND1 mRNA
CTD PMID:16328721, PMID:19800779 NCBI chr 7:144,929,931...144,939,831
Ensembl chr 7:144,929,931...144,939,925
JBrowse link
G Ccne1 cyclin E1 decreases expression ISO Coumestrol results in decreased expression of CCNE1 protein CTD PMID:28986287 NCBI chr 7:38,097,984...38,107,490
Ensembl chr 7:38,097,984...38,107,534
JBrowse link
G Ccne2 cyclin E2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNE2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CCNE2 mRNA
Coumestrol results in increased expression of CCNE2 mRNA
CTD PMID:19167446 NCBI chr 4:11,190,433...11,204,779
Ensembl chr 4:11,191,351...11,204,779
JBrowse link
G Ccnf cyclin F multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNF mRNA
Coumestrol results in increased expression of CCNF mRNA
CTD PMID:19167446 NCBI chr17:24,223,230...24,251,409
Ensembl chr17:24,222,198...24,251,484
JBrowse link
G Ccng2 cyclin G2 decreases expression ISO Coumestrol results in decreased expression of CCNG2 mRNA CTD PMID:19167446 NCBI chr 5:93,267,573...93,276,231
Ensembl chr 5:93,267,257...93,276,231
JBrowse link
G Ccni cyclin I decreases expression ISO Coumestrol results in decreased expression of CCNI mRNA CTD PMID:19167446 NCBI chr 5:93,181,933...93,206,495
Ensembl chr 5:93,181,933...93,206,495
JBrowse link
G Ccp110 centriolar coiled coil protein 110 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CP110 mRNA CTD PMID:19167446 NCBI chr 7:118,712,515...118,737,024
Ensembl chr 7:118,712,552...118,737,024
JBrowse link
G Ccpg1 cell cycle progression 1 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CCPG1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CCPG1 mRNA
CTD PMID:19167446 NCBI chr 9:72,985,402...73,016,340
Ensembl chr 9:72,985,429...73,016,340
JBrowse link
G Cd24a CD24a antigen multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CD24 mRNA CTD PMID:19167446 NCBI chr10:43,579,169...43,584,265
Ensembl chr10:43,578,284...43,584,265
JBrowse link
G Cd320 CD320 antigen increases expression ISO Coumestrol results in increased expression of CD320 mRNA CTD PMID:19167446 NCBI chr17:33,843,091...33,849,774
Ensembl chr17:33,843,091...33,849,774
JBrowse link
G Cd44 CD44 antigen multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of CD44 mRNA
Coumestrol results in increased expression of CD44 mRNA
CTD PMID:19167446 NCBI chr 2:102,811,141...102,901,669
Ensembl chr 2:102,811,141...102,901,665
JBrowse link
G Cd55 CD55 molecule, decay accelerating factor for complement decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CD55 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CD55 mRNA
CTD PMID:19167446 NCBI chr 1:130,429,798...130,465,009
Ensembl chr 1:130,439,027...130,462,744
JBrowse link
G Cd59b CD59b antigen multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CD59 mRNA CTD PMID:19167446 NCBI chr 2:104,069,781...104,085,790
Ensembl chr 2:104,069,849...104,091,187
JBrowse link
G Cdc14b CDC14 cell division cycle 14B decreases expression ISO Coumestrol results in decreased expression of CDC14B mRNA CTD PMID:19167446 NCBI chr13:64,192,545...64,274,988
Ensembl chr13:64,189,268...64,275,290
JBrowse link
G Cdc25a cell division cycle 25A increases expression
multiple interactions
ISO Coumestrol results in increased expression of CDC25A mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC25A mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDC25A mRNA
CTD PMID:19167446 NCBI chr 9:109,875,518...109,893,895
Ensembl chr 9:109,875,579...109,893,895
JBrowse link
G Cdc25c cell division cycle 25C increases expression
multiple interactions
ISO Coumestrol results in increased expression of CDC25C mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC25C mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDC25C mRNA
CTD PMID:19167446 NCBI chr18:34,732,993...34,751,564
Ensembl chr18:34,732,993...34,751,533
JBrowse link
G Cdc27 cell division cycle 27 increases expression
multiple interactions
ISO Coumestrol results in increased expression of CDC27 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC27 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDC27 mRNA
CTD PMID:19167446 NCBI chr11:104,502,524...104,550,620
Ensembl chr11:104,502,745...104,550,620
JBrowse link
G Cdc42bpb CDC42 binding protein kinase beta decreases expression ISO Coumestrol results in decreased expression of CDC42BPB mRNA CTD PMID:19167446 NCBI chr12:111,292,972...111,379,313
Ensembl chr12:111,292,976...111,377,718
JBrowse link
G Cdc45 cell division cycle 45 increases expression
multiple interactions
ISO Coumestrol results in increased expression of CDC45 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC45 mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of CDC45 mRNA
CTD PMID:19167446 NCBI chr16:18,780,447...18,811,972
Ensembl chr16:18,780,447...18,811,987
JBrowse link
G Cdc5l cell division cycle 5-like (S. pombe) increases expression ISO Coumestrol results in increased expression of CDC5L mRNA CTD PMID:19167446 NCBI chr17:45,391,887...45,433,707
Ensembl chr17:45,391,884...45,433,737
JBrowse link
G Cdc6 cell division cycle 6 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC6 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDC6 mRNA
Coumestrol results in increased expression of CDC6 mRNA
CTD PMID:19167446 NCBI chr11:98,907,709...98,923,942
Ensembl chr11:98,907,801...98,923,940
JBrowse link
G Cdc7 cell division cycle 7 (S. cerevisiae) multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC7 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDC7 mRNA
Coumestrol results in increased expression of CDC7 mRNA
CTD PMID:19167446 NCBI chr 5:106,964,315...106,984,440
Ensembl chr 5:106,964,322...106,984,432
JBrowse link
G Cdca2 cell division cycle associated 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDCA2 mRNA
Coumestrol results in increased expression of CDCA2 mRNA
CTD PMID:19167446 NCBI chr14:67,673,180...67,715,841
Ensembl chr14:67,676,331...67,715,841
JBrowse link
G Cdca3 cell division cycle associated 3 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA3 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CDCA3 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDCA3 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CDCA3 mRNA]
Coumestrol results in increased expression of CDCA3 mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr 6:124,829,530...124,833,701
Ensembl chr 6:124,829,547...124,833,701
JBrowse link
G Cdca4 cell division cycle associated 4 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA4 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDCA4 mRNA CTD PMID:19167446 NCBI chr12:112,820,229...112,829,521
Ensembl chr12:112,820,229...112,829,423
JBrowse link
G Cdca5 cell division cycle associated 5 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA5 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDCA5 mRNA
Coumestrol results in increased expression of CDCA5 mRNA
CTD PMID:19167446 NCBI chr19:6,085,097...6,091,773
Ensembl chr19:6,084,983...6,091,777
JBrowse link
G Cdca7l cell division cycle associated 7 like multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA7L mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDCA7L mRNA
Coumestrol results in increased expression of CDCA7L mRNA
CTD PMID:19167446 NCBI chr12:117,843,475...117,878,712
Ensembl chr12:117,804,289...117,878,706
JBrowse link
G Cdca8 cell division cycle associated 8 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA8 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDCA8 mRNA
Coumestrol results in increased expression of CDCA8 mRNA
CTD PMID:19167446 NCBI chr 4:124,918,465...124,936,917
Ensembl chr 4:124,918,465...124,939,311
JBrowse link
G Cdh12 cadherin 12 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDH12 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDH12 mRNA CTD PMID:19167446 NCBI chr15:20,448,878...21,598,421
Ensembl chr15:20,449,265...21,589,533
JBrowse link
G Cdk1 cyclin-dependent kinase 1 increases expression
multiple interactions
ISO Coumestrol results in increased expression of CDK1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDK1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDK1 mRNA
CTD PMID:19167446 NCBI chr10:69,335,146...69,352,912
Ensembl chr10:69,335,146...69,352,938
JBrowse link
G Cdk13 cyclin-dependent kinase 13 decreases expression ISO Coumestrol results in decreased expression of CDK13 mRNA CTD PMID:19167446 NCBI chr13:17,711,676...17,805,212
Ensembl chr13:17,710,315...17,805,097
JBrowse link
G Cdk17 cyclin-dependent kinase 17 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PCTK2 mRNA CTD PMID:19167446 NCBI chr10:93,160,876...93,251,094
Ensembl chr10:93,160,875...93,267,071
JBrowse link
G Cdk2 cyclin-dependent kinase 2 decreases expression ISO Coumestrol results in decreased expression of CDK2 protein CTD PMID:28986287 NCBI chr10:128,697,938...128,705,051
Ensembl chr10:128,697,939...128,705,031
JBrowse link
G Cdk2ap2 CDK2-associated protein 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDK2AP2 mRNA CTD PMID:19167446 NCBI chr19:4,096,206...4,099,019
Ensembl chr19:4,097,182...4,099,019
JBrowse link
G Cdk5rap2 CDK5 regulatory subunit associated protein 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDK5RAP2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDK5RAP2 mRNA
Coumestrol results in increased expression of CDK5RAP2 mRNA
CTD PMID:19167446 NCBI chr 4:70,216,855...70,410,435
Ensembl chr 4:70,216,856...70,410,443
JBrowse link
G Cdkl5 cyclin-dependent kinase-like 5 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CDKL5 mRNA CTD PMID:19167446 NCBI chr  X:160,784,308...160,994,681
Ensembl chr  X:160,771,923...160,994,704
JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A (P21) decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CDKN1A mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDKN1A mRNA
CTD PMID:19167446 NCBI chr17:29,090,979...29,100,722
Ensembl chr17:29,090,976...29,100,727
JBrowse link
G Cdkn1c cyclin-dependent kinase inhibitor 1C (P57) decreases expression ISO Coumestrol results in decreased expression of CDKN1C mRNA CTD PMID:19167446 NCBI chr 7:143,458,339...143,461,059
Ensembl chr 7:143,458,339...143,461,050
JBrowse link
G Cdkn2aip CDKN2A interacting protein decreases expression ISO Coumestrol results in decreased expression of CDKN2AIP mRNA CTD PMID:19167446 NCBI chr 8:47,709,344...47,713,931
Ensembl chr 8:47,709,344...47,713,932
JBrowse link
G Cdkn2b cyclin dependent kinase inhibitor 2B multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDKN2B mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of CDKN2B mRNA
Coumestrol results in decreased expression of CDKN2B mRNA
CTD PMID:19167446 NCBI chr 4:89,306,289...89,311,032
Ensembl chr 4:89,306,299...89,311,039
JBrowse link
G Cdkn2c cyclin dependent kinase inhibitor 2C multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDKN2C mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CDKN2C mRNA; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CDKN2C mRNA]
Coumestrol results in increased expression of CDKN2C mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr 4:109,660,876...109,666,756
Ensembl chr 4:109,660,876...109,667,189
JBrowse link
G Cdkn3 cyclin-dependent kinase inhibitor 3 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDKN3 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CDKN3 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDKN3 mRNA; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CDKN3 mRNA]
Coumestrol results in increased expression of CDKN3 mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr14:46,760,461...46,771,530
Ensembl chr14:46,760,541...46,771,669
JBrowse link
G Cds1 CDP-diacylglycerol synthase 1 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CDS1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDS1 mRNA
CTD PMID:19167446 NCBI chr 5:101,765,093...101,823,858
Ensembl chr 5:101,765,130...101,823,858
JBrowse link
G Cdt1 chromatin licensing and DNA replication factor 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDT1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDT1 mRNA
Coumestrol results in increased expression of CDT1 mRNA
CTD PMID:19167446 NCBI chr 8:122,568,015...122,573,130
Ensembl chr 8:122,568,015...122,573,554
JBrowse link
G Cdv3 carnitine deficiency-associated gene expressed in ventricle 3 multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of CDV3 mRNA
Coumestrol results in increased expression of CDV3 mRNA
CTD PMID:19167446 NCBI chr 9:103,353,102...103,365,835
Ensembl chr 9:103,353,094...103,365,840
JBrowse link
G Cdyl chromodomain protein, Y chromosome-like decreases expression ISO Coumestrol results in decreased expression of CDYL mRNA CTD PMID:19167446 NCBI chr13:35,659,818...35,874,064
Ensembl chr13:35,659,833...35,874,063
JBrowse link
G Cebpd CCAAT/enhancer binding protein (C/EBP), delta multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CEBPD mRNA CTD PMID:19167446 NCBI chr16:15,887,286...15,889,545
Ensembl chr16:15,887,286...15,891,031
JBrowse link
G Celsr2 cadherin, EGF LAG seven-pass G-type receptor 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CELSR2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CELSR2 mRNA
Coumestrol results in increased expression of CELSR2 mRNA
CTD PMID:19167446 NCBI chr 3:108,390,848...108,416,069
Ensembl chr 3:108,390,851...108,415,552
JBrowse link
G Cenpa centromere protein A multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPA mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CENPA mRNA
Coumestrol results in increased expression of CENPA mRNA
CTD PMID:19167446 NCBI chr 5:30,666,877...30,674,837
Ensembl chr 5:30,666,777...30,674,830
JBrowse link
G Cenpe centromere protein E increases expression
multiple interactions
ISO Coumestrol results in increased expression of CENPE mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of CENPE mRNA
CTD PMID:19167446 NCBI chr 3:135,212,563...135,273,540
Ensembl chr 3:135,212,537...135,273,611
JBrowse link
G Cenpf centromere protein F multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPF mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CENPF mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CENPF mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CENPF mRNA]
Coumestrol results in increased expression of CENPF mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr 1:189,640,606...189,688,107
Ensembl chr 1:189,640,606...189,688,086
JBrowse link
G Cenph centromere protein H increases expression
multiple interactions
ISO Coumestrol results in increased expression of CENPH mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPH mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CENPH mRNA
CTD PMID:19167446 NCBI chr13:100,759,674...100,775,903
Ensembl chr13:100,759,674...100,775,899
JBrowse link
G Cenpi centromere protein I increases expression
multiple interactions
ISO Coumestrol results in increased expression of CENPI mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPI mRNA
CTD PMID:19167446 NCBI chr  X:134,308,084...134,363,104
Ensembl chr  X:134,308,084...134,362,639
JBrowse link
G Cenpj centromere protein J increases expression ISO Coumestrol results in increased expression of CENPJ mRNA CTD PMID:19167446 NCBI chr14:56,526,761...56,575,489
Ensembl chr14:56,526,761...56,575,425
JBrowse link
G Cenpl centromere protein L increases expression
multiple interactions
ISO Coumestrol results in increased expression of CENPL mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPL mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CENPL mRNA
CTD PMID:19167446 NCBI chr 1:161,070,767...161,086,724
Ensembl chr 1:161,070,713...161,086,724
JBrowse link
G Cenpm centromere protein M multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of CENPM mRNA
Coumestrol results in increased expression of CENPM mRNA
CTD PMID:19167446 NCBI chr15:82,233,762...82,244,773
Ensembl chr15:82,233,779...82,244,748
JBrowse link
G Cenpn centromere protein N multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPN mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CENPN mRNA
Coumestrol results in increased expression of CENPN mRNA
CTD PMID:19167446 NCBI chr 8:116,921,716...116,941,504
Ensembl chr 8:116,921,730...116,941,507
JBrowse link
G Cenpo centromere protein O multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPO mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CENPO mRNA
Coumestrol results in increased expression of CENPO mRNA
CTD PMID:19167446 NCBI chr12:4,195,398...4,234,255
Ensembl chr12:4,196,004...4,234,294
JBrowse link
G Cenpq centromere protein Q multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPQ mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CENPQ mRNA
Coumestrol results in increased expression of CENPQ mRNA
CTD PMID:19167446 NCBI chr17:40,920,809...40,934,574
Ensembl chr17:40,923,051...40,935,047
JBrowse link
G Cenps centromere protein S multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPS mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CENPS mRNA
Coumestrol results in increased expression of CENPS mRNA
CTD PMID:19167446 NCBI chr 4:149,128,349...149,137,600
Ensembl chr 4:149,127,121...149,137,629
JBrowse link
G Cenpu centromere protein U multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPU mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CENPU mRNA
Coumestrol results in increased expression of CENPU mRNA
CTD PMID:19167446 NCBI chr 8:46,552,019...46,580,568
Ensembl chr 8:46,552,028...46,580,007
JBrowse link
G Cenpw centromere protein W multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPW mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CENPW mRNA
Coumestrol results in increased expression of CENPW mRNA
CTD PMID:19167446 NCBI chr10:30,196,009...30,200,603
Ensembl chr10:30,194,569...30,200,560
JBrowse link
G Cep128 centrosomal protein 128 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CEP128 mRNA CTD PMID:19167446 NCBI chr12:90,998,490...91,384,455
Ensembl chr12:90,998,492...91,384,409
JBrowse link
G Cep152 centrosomal protein 152 multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of CEP152 mRNA
Coumestrol results in increased expression of CEP152 mRNA
CTD PMID:19167446 NCBI chr 2:125,549,864...125,625,174
Ensembl chr 2:125,563,088...125,625,113
JBrowse link
G Cep192 centrosomal protein 192 increases expression ISO Coumestrol results in increased expression of CEP192 mRNA CTD PMID:19167446 NCBI chr18:67,800,054...67,885,170
Ensembl chr18:67,800,107...67,885,170
JBrowse link
G Cep55 centrosomal protein 55 increases expression
multiple interactions
ISO Coumestrol results in increased expression of CEP55 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP55 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CEP55 mRNA
CTD PMID:19167446 NCBI chr19:38,054,970...38,074,425
Ensembl chr19:38,055,011...38,074,423
JBrowse link
G Cep57 centrosomal protein 57 multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of CEP57 mRNA
Coumestrol results in increased expression of CEP57 mRNA
CTD PMID:19167446 NCBI chr 9:13,807,783...13,827,407
Ensembl chr 9:13,807,792...13,827,107
JBrowse link
G Cep57l1 centrosomal protein 57-like 1 increases expression ISO Coumestrol results in increased expression of CEP57L1 mRNA CTD PMID:19167446 NCBI chr10:41,718,840...41,809,868
Ensembl chr10:41,718,840...41,809,871
JBrowse link
G Cep78 centrosomal protein 78 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP78 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CEP78 mRNA
Coumestrol results in increased expression of CEP78 mRNA
CTD PMID:19167446 NCBI chr19:15,955,768...15,985,700
Ensembl chr19:15,955,773...15,984,989
JBrowse link
G Cep85 centrosomal protein 85 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP85 mRNA
Coumestrol results in increased expression of CEP85 mRNA
CTD PMID:19167446 NCBI chr 4:134,129,858...134,187,085
Ensembl chr 4:134,129,858...134,187,112
JBrowse link
G Cfap20 cilia and flagella associated protein 20 increases expression ISO Coumestrol results in increased expression of CFAP20 mRNA CTD PMID:19167446 NCBI chr 8:95,420,249...95,434,869
Ensembl chr 8:95,420,249...95,434,869
JBrowse link
G Cflar CASP8 and FADD-like apoptosis regulator decreases expression ISO Coumestrol results in decreased expression of CFLAR mRNA CTD PMID:19167446 NCBI chr 1:58,711,311...58,758,884
Ensembl chr 1:58,711,508...58,758,884
JBrowse link
G Cgn cingulin decreases expression ISO Coumestrol results in decreased expression of CGN mRNA CTD PMID:19167446 NCBI chr 3:94,760,069...94,787,725
Ensembl chr 3:94,760,069...94,786,515
JBrowse link
G Chac2 ChaC, cation transport regulator 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHAC2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CHAC2 mRNA
Coumestrol results in increased expression of CHAC2 mRNA
CTD PMID:19167446 NCBI chr11:30,976,707...30,986,365
Ensembl chr11:30,976,707...30,986,350
JBrowse link
G Chaf1a chromatin assembly factor 1, subunit A (p150) multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHAF1A mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CHAF1A mRNA
Coumestrol results in increased expression of CHAF1A mRNA
CTD PMID:19167446 NCBI chr17:56,040,416...56,068,026
Ensembl chr17:56,040,439...56,072,289
JBrowse link
G Chaf1b chromatin assembly factor 1, subunit B (p60) multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHAF1B mRNA
Coumestrol results in increased expression of CHAF1B mRNA
CTD PMID:19167446 NCBI chr16:93,883,900...93,906,115
Ensembl chr16:93,883,901...93,906,115
JBrowse link
G Chd2 chromodomain helicase DNA binding protein 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CHD2 mRNA CTD PMID:19167446 NCBI chr 7:73,426,652...73,541,746
Ensembl chr 7:73,426,638...73,541,830
JBrowse link
G Chd6 chromodomain helicase DNA binding protein 6 decreases expression ISO Coumestrol results in decreased expression of CHD6 mRNA CTD PMID:19167446 NCBI chr 2:160,946,978...161,109,086
Ensembl chr 2:160,946,978...161,109,075
JBrowse link
G Chek1 checkpoint kinase 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHEK1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CHEK1 mRNA
Coumestrol results in increased expression of CHEK1 mRNA
CTD PMID:19167446 NCBI chr 9:36,708,482...36,726,658
Ensembl chr 9:36,708,482...36,727,065
JBrowse link
G Chek2 checkpoint kinase 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHEK2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CHEK2 mRNA CTD PMID:19167446 NCBI chr 5:110,839,800...110,874,140
Ensembl chr 5:110,839,979...110,874,145
JBrowse link
G Chn1 chimerin 1 increases expression ISO Coumestrol results in increased expression of CHN1 mRNA CTD PMID:19167446 NCBI chr 2:73,610,660...73,775,367
Ensembl chr 2:73,610,660...73,775,346
JBrowse link
G Chpt1 choline phosphotransferase 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHPT1 mRNA CTD PMID:19167446 NCBI chr10:88,469,513...88,503,970
Ensembl chr10:88,452,745...88,504,073
JBrowse link
G Chrna5 cholinergic receptor, nicotinic, alpha polypeptide 5 increases expression ISO Coumestrol results in increased expression of CHRNA5 mRNA CTD PMID:19167446 NCBI chr 9:54,980,827...55,011,420
Ensembl chr 9:54,980,880...55,007,779
JBrowse link
G Cip2a cell proliferation regulating inhibitor of protein phosphatase 2A multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CIP2A mRNA CTD PMID:19167446 NCBI chr16:48,994,157...49,019,716
Ensembl chr16:48,994,185...49,019,709
JBrowse link
G Cisd1 CDGSH iron sulfur domain 1 increases expression ISO Coumestrol results in increased expression of CISD1 mRNA CTD PMID:19167446 NCBI chr10:71,330,494...71,344,849
Ensembl chr10:71,330,480...71,344,954
JBrowse link
G Cit citron multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CIT mRNA CTD PMID:19167446 NCBI chr 5:115,845,224...116,008,953
Ensembl chr 5:115,845,278...116,008,947
JBrowse link
G Cited2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CITED2 mRNA CTD PMID:19167446 NCBI chr10:17,723,228...17,725,674
Ensembl chr10:17,723,218...17,725,674
JBrowse link
G Ckap2 cytoskeleton associated protein 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CKAP2 mRNA CTD PMID:19167446 NCBI chr 8:22,168,149...22,185,819
Ensembl chr 8:22,168,160...22,185,819
JBrowse link
G Ckap2l cytoskeleton associated protein 2-like multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of CKAP2L mRNA
Coumestrol results in increased expression of CKAP2L mRNA
CTD PMID:19167446 NCBI chr 2:129,268,210...129,297,228
Ensembl chr 2:129,268,210...129,297,212
JBrowse link
G Ckap4 cytoskeleton-associated protein 4 decreases expression ISO Coumestrol results in decreased expression of CKAP4 mRNA CTD PMID:19167446 NCBI chr10:84,526,305...84,533,888
Ensembl chr10:84,526,305...84,534,062
JBrowse link
G Ckap5 cytoskeleton associated protein 5 increases expression
multiple interactions
ISO Coumestrol results in increased expression of CKAP5 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKAP5 mRNA
CTD PMID:19167446 NCBI chr 2:91,526,747...91,620,679
Ensembl chr 2:91,526,762...91,620,664
JBrowse link
G Cklf chemokine-like factor increases expression
multiple interactions
ISO Coumestrol results in increased expression of CKLF mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKLF mRNA
CTD PMID:19167446 NCBI chr 8:104,250,861...104,266,010
Ensembl chr 8:104,250,861...104,264,938
JBrowse link
G Cks1b CDC28 protein kinase 1b multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKS1B mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CKS1B mRNA
Coumestrol results in increased expression of CKS1B mRNA
CTD PMID:19167446 NCBI chr 3:89,415,472...89,418,291
Ensembl chr 3:89,415,472...89,418,383
JBrowse link
G Cks2 CDC28 protein kinase regulatory subunit 2 increases expression
multiple interactions
ISO Coumestrol results in increased expression of CKS2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKS2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CKS2 mRNA
CTD PMID:19167446 NCBI chr13:51,645,232...51,650,662
Ensembl chr13:51,645,232...51,650,660
JBrowse link
G Clcc1 chloride channel CLIC-like 1 multiple interactions ISO [Coumestrol co-treated with ESR1 protein] results in increased expression of CLCC1 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CLCC1 mRNA] CTD PMID:18310284 NCBI chr 3:108,653,878...108,678,840
Ensembl chr 3:108,653,913...108,678,840
JBrowse link
G Cldn1 claudin 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLDN1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of CLDN1 mRNA CTD PMID:19167446 NCBI chr16:26,356,645...26,371,839
Ensembl chr16:26,356,642...26,371,841
JBrowse link
G Cldn4 claudin 4 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLDN4 mRNA CTD PMID:19167446 NCBI chr 5:134,945,123...134,946,934
Ensembl chr 5:134,945,119...134,946,934
JBrowse link
G Clip1 CAP-GLY domain containing linker protein 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLIP1 mRNA CTD PMID:19167446 NCBI chr 5:123,577,794...123,684,606
Ensembl chr 5:123,577,795...123,684,618
JBrowse link
G Cln6 ceroid-lipofuscinosis, neuronal 6 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CLN6 mRNA CTD PMID:19167446 NCBI chr 9:62,838,785...62,852,006
Ensembl chr 9:62,838,785...62,852,006
JBrowse link
G Cln8 CLN8 transmembrane ER and ERGIC protein decreases expression ISO Coumestrol results in decreased expression of CLN8 mRNA CTD PMID:19167446 NCBI chr 8:14,881,335...14,901,720
Ensembl chr 8:14,881,335...14,901,720
JBrowse link
G Cltrn collectrin, amino acid transport regulator decreases expression ISO Coumestrol results in decreased expression of CLTRN mRNA CTD PMID:19167446 NCBI chr  X:164,090,187...164,118,859
Ensembl chr  X:164,088,830...164,118,860
JBrowse link
G Clu clusterin multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLU mRNA CTD PMID:19167446 NCBI chr14:65,968,483...65,981,548
Ensembl chr14:65,968,483...65,981,547
JBrowse link
G Cmc2 COX assembly mitochondrial protein 2 increases expression
multiple interactions
ISO Coumestrol results in increased expression of CMC2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CMC2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CMC2 mRNA
CTD PMID:19167446 NCBI chr 8:116,888,685...116,944,322
Ensembl chr 8:116,888,685...116,921,455
JBrowse link
G Cmss1 cms small ribosomal subunit 1 increases expression
multiple interactions
ISO Coumestrol results in increased expression of CMSS1 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of CMSS1 mRNA
CTD PMID:19167446 NCBI chr16:57,301,999...57,606,867
Ensembl chr16:57,302,000...57,606,864
JBrowse link
G Cmtm8 CKLF-like MARVEL transmembrane domain containing 8 decreases expression ISO Coumestrol results in decreased expression of CMTM8 mRNA CTD PMID:19167446 NCBI chr 9:114,789,343...114,844,152
Ensembl chr 9:114,789,345...114,844,156
JBrowse link
G Cobl cordon-bleu WH2 repeat decreases expression ISO Coumestrol results in decreased expression of COBL mRNA CTD PMID:19167446 NCBI chr11:12,236,676...12,465,022
Ensembl chr11:12,236,608...12,464,960
JBrowse link
G Coch cochlin increases expression ISO Coumestrol results in increased expression of COCH mRNA CTD PMID:19167446 NCBI chr12:51,593,283...51,606,619
Ensembl chr12:51,593,341...51,605,771
JBrowse link
G Cog4 component of oligomeric golgi complex 4 increases expression ISO Coumestrol results in increased expression of COG4 mRNA CTD PMID:19167446 NCBI chr 8:110,846,600...110,882,234
Ensembl chr 8:110,846,600...110,882,227
JBrowse link
G Cog5 component of oligomeric golgi complex 5 decreases expression ISO Coumestrol results in decreased expression of COG5 mRNA CTD PMID:19167446 NCBI chr12:31,654,819...31,937,630
Ensembl chr12:31,654,869...31,937,630
JBrowse link
G Cog6 component of oligomeric golgi complex 6 decreases expression ISO Coumestrol results in decreased expression of COG6 mRNA CTD PMID:19167446 NCBI chr 3:52,982,123...53,017,223
Ensembl chr 3:52,981,875...53,017,237
JBrowse link
G Commd4 COMM domain containing 4 increases expression ISO Coumestrol results in increased expression of COMMD4 mRNA CTD PMID:19167446 NCBI chr 9:57,155,035...57,158,349
Ensembl chr 9:57,155,035...57,158,331
JBrowse link
G Comt catechol-O-methyltransferase decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of COMT mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of COMT mRNA
CTD PMID:19167446 NCBI chr16:18,406,882...18,426,716
Ensembl chr16:18,406,886...18,426,852
JBrowse link
G Cops2 COP9 signalosome subunit 2 decreases expression ISO Coumestrol results in decreased expression of COPS2 mRNA CTD PMID:19167446 NCBI chr 2:125,830,302...125,859,082
Ensembl chr 2:125,830,304...125,859,139
JBrowse link
G Coq2 coenzyme Q2 4-hydroxybenzoate polyprenyltransferase multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of COQ2 mRNA CTD PMID:19167446 NCBI chr 5:100,654,723...100,674,288
Ensembl chr 5:100,654,723...100,675,140
JBrowse link
G Coq7 demethyl-Q 7 increases expression ISO Coumestrol results in increased expression of COQ7 mRNA CTD PMID:19167446 NCBI chr 7:118,509,659...118,533,356
Ensembl chr 7:118,509,659...118,533,356
JBrowse link
G Coro1b coronin, actin binding protein 1B decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CORO1B mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of CORO1B mRNA
CTD PMID:19167446 NCBI chr19:4,148,611...4,154,035
Ensembl chr19:4,148,619...4,154,035
JBrowse link
G Coro1c coronin, actin binding protein 1C increases expression ISO Coumestrol results in increased expression of CORO1C mRNA CTD PMID:19167446 NCBI chr 5:113,842,439...113,908,706
Ensembl chr 5:113,842,436...113,908,758
JBrowse link
G Coro2a coronin, actin binding protein 2A decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CORO2A mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of CORO2A mRNA
CTD PMID:19167446 NCBI chr 4:46,536,937...46,601,929
Ensembl chr 4:46,536,937...46,602,202
JBrowse link
G Cpe carboxypeptidase E decreases expression ISO Coumestrol results in decreased expression of CPE mRNA CTD PMID:19167446 NCBI chr 8:64,592,542...64,693,109
Ensembl chr 8:64,592,542...64,693,054
JBrowse link
G Cpeb2 cytoplasmic polyadenylation element binding protein 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CPEB2 mRNA CTD PMID:19167446 NCBI chr 5:43,225,349...43,289,724
Ensembl chr 5:43,233,170...43,289,724
JBrowse link
G Cpsf3 cleavage and polyadenylation specificity factor 3 increases expression ISO Coumestrol results in increased expression of CPSF3 mRNA CTD PMID:19167446 NCBI chr12:21,286,273...21,315,056
Ensembl chr12:21,285,391...21,315,056
JBrowse link
G Cracd capping protein inhibiting regulator of actin multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CRACD mRNA
Coumestrol results in decreased expression of CRACD mRNA
CTD PMID:19167446 NCBI chr 5:76,657,629...76,873,554
Ensembl chr 5:76,656,512...76,873,554
JBrowse link
G Creb3l4 cAMP responsive element binding protein 3-like 4 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CREB3L4 mRNA CTD PMID:19167446 NCBI chr 3:90,237,498...90,244,582
Ensembl chr 3:90,237,500...90,243,512
JBrowse link
G Crip2 cysteine rich protein 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CRIP2 mRNA CTD PMID:19167446 NCBI chr12:113,140,236...113,145,506
Ensembl chr12:113,140,236...113,145,506
JBrowse link
G Cry1 cryptochrome 1 (photolyase-like) decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CRY1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CRY1 mRNA
CTD PMID:19167446 NCBI chr10:85,131,700...85,185,054
Ensembl chr10:85,131,700...85,185,064
JBrowse link
G Cse1l chromosome segregation 1-like (S. cerevisiae) multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CSE1L mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CSE1L mRNA
Coumestrol results in increased expression of CSE1L mRNA
CTD PMID:19167446 NCBI chr 2:166,906,041...166,946,389
Ensembl chr 2:166,906,040...166,946,389
JBrowse link
G Csnk1a1 casein kinase 1, alpha 1 decreases expression ISO Coumestrol results in decreased expression of CSNK1A1 mRNA CTD PMID:19167446 NCBI chr18:61,554,236...61,590,320
Ensembl chr18:61,555,274...61,590,061
JBrowse link
G Csnk1g1 casein kinase 1, gamma 1 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CSNK1G1 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of CSNK1G1 mRNA
CTD PMID:19167446 NCBI chr 9:65,908,968...66,045,015
Ensembl chr 9:65,908,924...66,045,015
JBrowse link
G Csnk1g3 casein kinase 1, gamma 3 decreases expression ISO Coumestrol results in decreased expression of CSNK1G3 mRNA CTD PMID:19167446 NCBI chr18:53,862,082...53,955,684
Ensembl chr18:53,862,122...53,955,548
JBrowse link
G Csnk2a2 casein kinase 2, alpha prime polypeptide decreases expression ISO Coumestrol results in decreased expression of CSNK2A2 mRNA CTD PMID:19167446 NCBI chr 8:95,446,096...95,488,868
Ensembl chr 8:95,446,096...95,490,039
JBrowse link
G Cspg5 chondroitin sulfate proteoglycan 5 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CSPG5 mRNA CTD PMID:19167446 NCBI chr 9:110,243,783...110,262,576
Ensembl chr 9:110,243,783...110,262,576
JBrowse link
G Csrnp1 cysteine-serine-rich nuclear protein 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AXUD1 mRNA
Coumestrol results in decreased expression of AXUD1 mRNA
CTD PMID:19167446 NCBI chr 9:119,971,163...119,984,742
Ensembl chr 9:119,971,163...119,984,658
JBrowse link
G Csrnp2 cysteine-serine-rich nuclear protein 2 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CSRNP2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CSRNP2 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of CSRNP2 mRNA
CTD PMID:19167446 NCBI chr15:100,479,570...100,495,239
Ensembl chr15:100,479,570...100,495,488
JBrowse link
G Csta1 cystatin A1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CSTA mRNA
Coumestrol results in decreased expression of CSTA mRNA
CTD PMID:19167446 NCBI chr16:36,119,946...36,131,189
Ensembl chr16:36,119,946...36,131,241
JBrowse link
G Cstf1 cleavage stimulation factor, 3' pre-RNA, subunit 1 increases expression ISO Coumestrol results in increased expression of CSTF1 mRNA CTD PMID:19167446 NCBI chr 2:172,370,645...172,382,449
Ensembl chr 2:172,370,681...172,382,448
JBrowse link
G Cstf2 cleavage stimulation factor, 3' pre-RNA subunit 2 increases expression ISO Coumestrol results in increased expression of CSTF2 mRNA CTD PMID:19167446 NCBI chr  X:134,059,176...134,086,822
Ensembl chr  X:134,059,187...134,086,819
JBrowse link
G Ctbp1 C-terminal binding protein 1 decreases expression ISO Coumestrol results in decreased expression of CTBP1 mRNA CTD PMID:19167446 NCBI chr 5:33,247,723...33,275,004
Ensembl chr 5:33,247,723...33,274,994
JBrowse link
G Ctdspl2 CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTDSPL2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CTDSPL2 mRNA
Coumestrol results in increased expression of CTDSPL2 mRNA
CTD PMID:19167446 NCBI chr 2:121,955,398...122,015,326
Ensembl chr 2:121,956,001...122,013,642
JBrowse link
G Ctnnal1 catenin (cadherin associated protein), alpha-like 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTNNAL1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CTNNAL1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CTNNAL1 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CTNNAL1 mRNA]
Coumestrol results in increased expression of CTNNAL1 mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr 4:56,810,935...56,865,375
Ensembl chr 4:56,810,935...56,865,188
JBrowse link
G Ctnnd1 catenin (cadherin associated protein), delta 1 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CTNND1 mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of CTNND1 mRNA
CTD PMID:19167446 NCBI chr 2:84,587,096...84,658,977
Ensembl chr 2:84,600,071...84,650,765
Ensembl chr 2:84,600,071...84,650,765
JBrowse link
G Ctnnd2 catenin (cadherin associated protein), delta 2 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CTNND2 mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of CTNND2 mRNA
CTD PMID:19167446 NCBI chr15:30,172,534...31,029,344
Ensembl chr15:30,172,593...31,029,341
JBrowse link
G Ctps cytidine 5'-triphosphate synthase multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of CTPS mRNA
Coumestrol results in increased expression of CTPS mRNA
CTD PMID:19167446 NCBI chr 4:120,539,868...120,570,276
Ensembl chr 4:120,539,868...120,570,276
JBrowse link
G Ctr9 CTR9 homolog, Paf1/RNA polymerase II complex component multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTR9 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CTR9 mRNA CTD PMID:19167446 NCBI chr 7:111,028,951...111,056,377
Ensembl chr 7:111,028,951...111,056,377
JBrowse link
G Ctsb cathepsin B decreases expression ISO Coumestrol results in decreased expression of CTSB mRNA CTD PMID:19167446 NCBI chr14:63,122,462...63,145,923
Ensembl chr14:63,122,462...63,145,923
JBrowse link
G Ctsc cathepsin C increases expression ISO Coumestrol results in increased expression of CTSC mRNA CTD PMID:19167446 NCBI chr 7:88,278,024...88,315,861
Ensembl chr 7:88,278,085...88,310,888
JBrowse link
G Ctsh cathepsin H multiple interactions
decreases expression
ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CTSH mRNA
Coumestrol results in decreased expression of CTSH mRNA
CTD PMID:19167446 NCBI chr 9:90,054,267...90,076,095
Ensembl chr 9:90,054,152...90,076,089
JBrowse link
G Cttn cortactin multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CTTN mRNA CTD PMID:19167446 NCBI chr 7:144,435,724...144,471,560
Ensembl chr 7:144,435,733...144,471,009
JBrowse link
G Cttnbp2nl CTTNBP2 N-terminal like multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CTTNBP2NL mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of CTTNBP2NL mRNA CTD PMID:19167446 NCBI chr 3:105,001,915...105,053,146
Ensembl chr 3:105,001,915...105,053,146
JBrowse link
G Cxcl12 chemokine (C-X-C motif) ligand 12 multiple interactions
increases expression
ISO [Coumestrol co-treated with ESR1 protein] results in increased expression of CXCL12 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CXCL12 mRNA; ESR1 protein inhibits the reaction [Coumestrol results in increased expression of CXCL12 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CXCL12 mRNA] CTD PMID:18310284, PMID:19167446, PMID:23384675, PMID:28396216 NCBI chr 6:117,168,535...117,181,368
Ensembl chr 6:117,168,535...117,181,367
JBrowse link
G Cxxc5 CXXC finger 5 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CXXC5 mRNA CTD PMID:19167446 NCBI chr18:35,829,379...35,861,693
Ensembl chr18:35,829,397...35,861,688
JBrowse link
G Cyb5b cytochrome b5 type B increases expression ISO Coumestrol results in increased expression of CYB5B mRNA CTD PMID:19167446 NCBI chr 8:107,150,661...107,187,470
Ensembl chr 8:107,150,640...107,187,471
JBrowse link
G Cyb5r1 cytochrome b5 reductase 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CYB5R1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of CYB5R1 mRNA CTD PMID:19167446 NCBI chr 1:134,405,781...134,411,738
Ensembl chr 1:134,405,559...134,411,740
JBrowse link
G Cyfip2 cytoplasmic FMR1 interacting protein 2 decreases expression ISO Coumestrol results in decreased expression of CYFIP2 mRNA CTD PMID:19167446 NCBI chr11:46,193,849...46,312,859
Ensembl chr11:46,193,850...46,312,859
JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 increases expression
multiple interactions
ISO Coumestrol results in increased expression of CYP1B1 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of CYP1B1 mRNA
CTD PMID:19167446 NCBI chr17:79,706,940...79,715,061
Ensembl chr17:79,701,537...79,715,061
JBrowse link
G Cyp2r1 cytochrome P450, family 2, subfamily r, polypeptide 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CYP2R1 mRNA CTD PMID:19167446 NCBI chr 7:114,550,123...114,563,048
Ensembl chr 7:114,549,682...114,562,972
JBrowse link
G Cyp51 cytochrome P450, family 51 increases expression ISO Coumestrol results in increased expression of CYP51A1 mRNA CTD PMID:19167446 NCBI chr 5:4,080,674...4,104,697
Ensembl chr 5:4,081,145...4,104,746
JBrowse link
G Cyren cell cycle regulator of NHEJ increases expression ISO Coumestrol results in increased expression of CYREN mRNA CTD PMID:19167446 NCBI chr 6:34,871,771...34,878,065
Ensembl chr 6:34,871,771...34,878,060
JBrowse link
G Cyrib CYFIP related Rac1 interactor B decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CYRIB mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CYRIB mRNA
CTD PMID:19167446 NCBI chr15:63,929,094...64,060,778
Ensembl chr15:63,929,097...64,060,478
JBrowse link
G Cyth2 cytohesin 2 decreases expression ISO Coumestrol results in decreased expression of CYTH2 mRNA CTD PMID:19167446 NCBI chr 7:45,806,637...45,814,322
Ensembl chr 7:45,806,637...45,814,581
JBrowse link
G D030056L22Rik RIKEN cDNA D030056L22 gene increases expression
multiple interactions
ISO Coumestrol results in increased expression of C9ORF40 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C9ORF40 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of C9ORF40 mRNA
CTD PMID:19167446 NCBI chr19:18,713,235...18,718,429
Ensembl chr19:18,713,193...18,718,428
JBrowse link
G D630039A03Rik RIKEN cDNA D630039A03 gene decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of C9ORF152 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of C9ORF152 mRNA
CTD PMID:19167446 NCBI chr 4:57,908,384...57,916,264
Ensembl chr 4:57,908,483...57,916,297
JBrowse link
G Daam1 dishevelled associated activator of morphogenesis 1 decreases expression ISO Coumestrol results in decreased expression of DAAM1 mRNA CTD PMID:19167446 NCBI chr12:71,830,950...71,992,376
Ensembl chr12:71,831,078...71,992,333
JBrowse link
G Dancr differentiation antagonizing non-protein coding RNA multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DANCR mRNA CTD PMID:19167446 NCBI chr 5:74,093,060...74,094,337
Ensembl chr 5:74,093,060...74,095,406
JBrowse link
G Dars2 aspartyl-tRNA synthetase 2 (mitochondrial) increases expression
multiple interactions
ISO Coumestrol results in increased expression of DARS2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DARS2 mRNA
CTD PMID:19167446 NCBI chr 1:161,037,580...161,070,668
Ensembl chr 1:161,040,601...161,070,658
JBrowse link
G Dbf4 DBF4 zinc finger multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DBF4 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DBF4 mRNA
Coumestrol results in increased expression of DBF4 mRNA
CTD PMID:19167446 NCBI chr 5:8,396,969...8,422,725
Ensembl chr 5:8,396,973...8,422,716
JBrowse link
G Dbn1 drebrin 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DBN1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of DBN1 mRNA
Coumestrol results in decreased expression of DBN1 mRNA
CTD PMID:19167446 NCBI chr13:55,473,428...55,488,126
Ensembl chr13:55,473,429...55,488,111
JBrowse link
G Dcaf15 DDB1 and CUL4 associated factor 15 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCAF15 mRNA CTD PMID:19167446 NCBI chr 8:84,097,069...84,104,797
Ensembl chr 8:84,097,072...84,104,768
JBrowse link
G Dcaf4 DDB1 and CUL4 associated factor 4 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCAF4 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of DCAF4 mRNA CTD PMID:19167446 NCBI chr12:83,520,447...83,541,994
Ensembl chr12:83,520,466...83,541,920
JBrowse link
G Dcaf5 DDB1 and CUL4 associated factor 5 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of DCAF5 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCAF5 mRNA
CTD PMID:19167446 NCBI chr12:80,335,848...80,436,601
Ensembl chr12:80,335,848...80,436,601
JBrowse link
G Dck deoxycytidine kinase increases expression
multiple interactions
ISO Coumestrol results in increased expression of DCK mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of DCK mRNA
CTD PMID:19167446 NCBI chr 5:88,765,013...88,783,277
Ensembl chr 5:88,764,996...88,783,281
JBrowse link
G Dclk1 doublecortin-like kinase 1 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of DCLK1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCLK1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of DCLK1 mRNA
CTD PMID:19167446 NCBI chr 3:55,242,303...55,539,068
Ensembl chr 3:55,242,364...55,539,068
JBrowse link
G Dclre1a DNA cross-link repair 1A increases expression
multiple interactions
ISO Coumestrol results in increased expression of DCLRE1A mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCLRE1A mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DCLRE1A mRNA
CTD PMID:19167446 NCBI chr19:56,529,161...56,548,284
Ensembl chr19:56,529,167...56,548,222
JBrowse link
G Dclre1b DNA cross-link repair 1B multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCLRE1B mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DCLRE1B mRNA
Coumestrol results in increased expression of DCLRE1B mRNA
CTD PMID:19167446 NCBI chr 3:103,800,605...103,809,387
Ensembl chr 3:103,800,605...103,809,444
JBrowse link
G Dcps decapping enzyme, scavenger increases expression ISO Coumestrol results in increased expression of DCPS mRNA CTD PMID:19167446 NCBI chr 9:35,124,414...35,175,987
Ensembl chr 9:35,124,408...35,176,061
JBrowse link
G Dctpp1 dCTP pyrophosphatase 1 increases expression ISO Coumestrol results in increased expression of DCTPP1 mRNA CTD PMID:19167446 NCBI chr 7:127,256,959...127,260,667
Ensembl chr 7:127,256,959...127,260,709
JBrowse link
G Ddah2 dimethylarginine dimethylaminohydrolase 2 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of DDAH2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DDAH2 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of DDAH2 mRNA
CTD PMID:19167446 NCBI chr17:35,059,035...35,062,099
Ensembl chr17:35,059,035...35,062,095
JBrowse link
G Ddb2 damage specific DNA binding protein 2 increases expression
multiple interactions
ISO Coumestrol results in increased expression of DDB2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DDB2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DDB2 mRNA
CTD PMID:19167446 NCBI chr 2:91,211,545...91,237,132
Ensembl chr 2:91,211,572...91,236,982
JBrowse link
G Ddias DNA damage-induced apoptosis suppressor multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DDIAS mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DDIAS mRNA
Coumestrol results in increased expression of DDIAS mRNA
CTD PMID:19167446 NCBI chr 7:92,857,525...92,874,917
Ensembl chr 7:92,857,525...92,874,247
JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of DDIT4 mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of DDIT4 mRNA
CTD PMID:19167446 NCBI chr10:59,949,675...59,951,770
Ensembl chr10:59,949,669...59,951,834
JBrowse link
G Ddx11 DEAD/H box helicase 11 increases expression ISO Coumestrol results in increased expression of DDX11 mRNA CTD PMID:19167446 NCBI chr17:66,123,513...66,152,174
Ensembl chr17:66,123,520...66,152,174
JBrowse link
G Ddx39a DEAD box helicase 39a increases expression ISO Coumestrol results in increased expression of DDX39A mRNA CTD PMID:19167446 NCBI chr 8:83,715,177...83,726,904
Ensembl chr 8:83,715,177...83,726,892
JBrowse link
G Ddx39b DEAD box helicase 39b multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DDX39B mRNA CTD PMID:19167446 NCBI chr17:35,241,746...35,253,707
Ensembl chr17:35,241,746...35,253,707
JBrowse link
G Ddx56 DEAD box helicase 56 increases expression ISO Coumestrol results in increased expression of DDX56 mRNA CTD PMID:19167446 NCBI chr11:6,257,545...6,269,786
Ensembl chr11:6,258,919...6,267,772
JBrowse link
G Dek DEK proto-oncogene (DNA binding) increases expression
multiple interactions
ISO Coumestrol results in increased expression of DEK mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of DEK mRNA
CTD PMID:19167446 NCBI chr13:47,084,767...47,107,530
Ensembl chr13:47,084,775...47,106,201
JBrowse link
G Dennd11 DENN domain containing 11 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of DENND11 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DENND11 mRNA
CTD PMID:19167446 NCBI chr 6:40,401,375...40,436,135
Ensembl chr 6:40,401,375...40,436,135
JBrowse link
G Dennd1a DENN/MADD domain containing 1A increases expression ISO Coumestrol results in increased expression of DENND1A mRNA CTD PMID:19167446 NCBI chr 2:37,798,990...38,287,410
Ensembl chr 2:37,798,991...38,287,390
JBrowse link
G Dennd1b DENN/MADD domain containing 1B decreases expression ISO Coumestrol results in decreased expression of DENND1B mRNA CTD PMID:19167446 NCBI chr 1:138,963,709...139,176,043
Ensembl chr 1:138,963,435...139,178,960
JBrowse link
G Dennd1c DENN/MADD domain containing 1C decreases expression ISO Coumestrol results in decreased expression of DENND1C mRNA CTD PMID:19167446 NCBI chr17:57,066,051...57,078,529
Ensembl chr17:57,065,905...57,078,514
JBrowse link
G Denr density-regulated protein increases expression ISO Coumestrol results in increased expression of DENR mRNA CTD PMID:19167446 NCBI chr 5:123,907,205...123,928,832
Ensembl chr 5:123,907,175...123,928,835
JBrowse link
G Depdc1a DEP domain containing 1a multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DEPDC1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of DEPDC1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DEPDC1 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of DEPDC1 mRNA]
Coumestrol results in increased expression of DEPDC1 mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr 3:159,495,414...159,529,955
Ensembl chr 3:159,495,433...159,529,955
JBrowse link
G Depdc1b DEP domain containing 1B multiple interactions ISO [Coumestrol co-treated with ESR1 protein] results in increased expression of DEPDC1B mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of DEPDC1B mRNA] CTD PMID:18310284 NCBI chr13:108,316,014...108,389,566
Ensembl chr13:108,316,332...108,407,782
JBrowse link
G Deptor DEP domain containing MTOR-interacting protein increases expression
multiple interactions
ISO Coumestrol results in increased expression of DEPTOR mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DEPTOR mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of DEPTOR mRNA
CTD PMID:19167446 NCBI chr15:55,112,317...55,259,273
Ensembl chr15:55,112,317...55,259,271
JBrowse link
G Dera deoxyribose-phosphate aldolase (putative) multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DERA mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DERA mRNA
Coumestrol results in increased expression of DERA mRNA
CTD PMID:19167446 NCBI chr 6:137,754,577...137,837,872
Ensembl chr 6:137,754,546...137,857,340
JBrowse link
G Desi2 desumoylating isopeptidase 2 increases expression ISO Coumestrol results in increased expression of DESI2 mRNA CTD PMID:19167446 NCBI chr 1:178,187,417...178,252,598
Ensembl chr 1:178,187,417...178,257,301
JBrowse link
G Dhcr7 7-dehydrocholesterol reductase multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of DHCR7 mRNA
Coumestrol results in increased expression of DHCR7 mRNA
CTD PMID:19167446 NCBI chr 7:143,823,167...143,848,410
Ensembl chr 7:143,823,145...143,848,410
JBrowse link
G Dhfr dihydrofolate reductase multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DHFR mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DHFR mRNA
Coumestrol results in increased expression of DHFR mRNA
CTD PMID:19167446 NCBI chr13:92,354,783...92,389,053
Ensembl chr13:92,354,726...92,389,053
JBrowse link
G Dhrs2 dehydrogenase/reductase member 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DHRS2 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of DHRS2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DHRS2 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of DHRS2 mRNA]
Coumestrol results in increased expression of DHRS2 mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr14:55,222,007...55,241,440
Ensembl chr14:55,222,007...55,241,435
JBrowse link
G Dhrs7 dehydrogenase/reductase (SDR family) member 7 decreases expression ISO Coumestrol results in decreased expression of DHRS7 mRNA CTD PMID:19167446 NCBI chr12:72,650,353...72,664,828
Ensembl chr12:72,650,353...72,664,909
JBrowse link
G Dhtkd1 dehydrogenase E1 and transketolase domain containing 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DHTKD1 mRNA
Coumestrol results in increased expression of DHTKD1 mRNA
CTD PMID:19167446 NCBI chr 2:5,896,219...5,942,829
Ensembl chr 2:5,896,115...5,942,792
JBrowse link
G Diaph3 diaphanous related formin 3 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DIAPH3 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DIAPH3 mRNA CTD PMID:19167446 NCBI chr14:86,655,357...87,141,247
Ensembl chr14:86,655,367...87,141,235
JBrowse link
G Dicer1 dicer 1, ribonuclease type III decreases expression ISO Coumestrol results in decreased expression of DICER1 mRNA CTD PMID:19167446 NCBI chr12:104,687,740...104,751,968
Ensembl chr12:104,687,742...104,751,952
JBrowse link
G Dip2c disco interacting protein 2 homolog C multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DIP2C mRNA CTD PMID:19167446 NCBI chr13:9,276,507...9,668,928
Ensembl chr13:9,276,528...9,668,928
JBrowse link
G Dixdc1 DIX domain containing 1 decreases expression ISO Coumestrol results in decreased expression of DIXDC1 mRNA CTD PMID:19167446 NCBI chr 9:50,662,752...50,739,602
Ensembl chr 9:50,662,752...50,739,517
JBrowse link
G Dkc1 dyskeratosis congenita 1, dyskerin increases expression
multiple interactions
ISO Coumestrol results in increased expression of DKC1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DKC1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DKC1 mRNA
CTD PMID:19167446 NCBI chr  X:75,095,854...75,109,776
Ensembl chr  X:75,095,854...75,109,777
JBrowse link
G Dlat dihydrolipoamide S-acetyltransferase (E2 component of pyruvate dehydrogenase complex) increases expression ISO Coumestrol results in increased expression of DLAT mRNA CTD PMID:19167446 NCBI chr 9:50,634,633...50,659,780
Ensembl chr 9:50,634,633...50,659,780
JBrowse link
G Dlgap5 DLG associated protein 5 increases expression
multiple interactions
ISO Coumestrol results in increased expression of DLGAP5 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DLGAP5 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DLGAP5 mRNA
CTD PMID:19167446 NCBI chr14:47,387,779...47,418,407
Ensembl chr14:47,387,779...47,418,407
JBrowse link
G Dlx2 distal-less homeobox 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DLX2 mRNA CTD PMID:19167446 NCBI chr 2:71,543,408...71,546,754
Ensembl chr 2:71,543,408...71,546,754
JBrowse link
G Dmac2l distal membrane arm assembly complex 2 like decreases expression ISO Coumestrol results in decreased expression of DMAC2L mRNA CTD PMID:19167446 NCBI chr12:69,724,913...69,744,665
Ensembl chr12:69,724,950...69,744,660
JBrowse link
G Dmxl1 Dmx-like 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DMXL1 mRNA CTD PMID:19167446 NCBI chr18:49,832,590...49,965,473
Ensembl chr18:49,832,670...49,965,473
JBrowse link
G Dna2 DNA replication helicase/nuclease 2 increases expression ISO Coumestrol results in increased expression of DNA2 mRNA CTD PMID:19167446 NCBI chr10:62,946,983...62,974,188
Ensembl chr10:62,947,026...62,974,185
JBrowse link
G Dnaja2 DnaJ heat shock protein family (Hsp40) member A2 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of DNAJA2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNAJA2 mRNA
CTD PMID:19167446 NCBI chr 8:85,537,633...85,555,361
Ensembl chr 8:85,537,633...85,555,344
JBrowse link
G Dnajb9 DnaJ heat shock protein family (Hsp40) member B9 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of DNAJB9 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNAJB9 mRNA
CTD PMID:19167446 NCBI chr12:44,205,897...44,210,068
Ensembl chr12:44,205,559...44,210,326
JBrowse link
G Dnajc1 DnaJ heat shock protein family (Hsp40) member C1 decreases expression ISO Coumestrol results in decreased expression of DNAJC1 mRNA CTD PMID:19167446 NCBI chr 2:18,205,634...18,394,099
Ensembl chr 2:18,195,654...18,392,830
JBrowse link
G Dnajc16 DnaJ heat shock protein family (Hsp40) member C16 decreases expression ISO Coumestrol results in decreased expression of DNAJC16 mRNA CTD PMID:19167446 NCBI chr 4:141,761,998...141,790,644
Ensembl chr 4:141,760,189...141,790,931
JBrowse link
G Dnajc9 DnaJ heat shock protein family (Hsp40) member C9 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNAJC9 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DNAJC9 mRNA
Coumestrol results in increased expression of DNAJC9 mRNA
CTD PMID:19167446 NCBI chr14:20,384,638...20,388,910
Ensembl chr14:20,384,638...20,388,910
JBrowse link
G Dnase2a deoxyribonuclease II alpha multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNASE2 mRNA CTD PMID:19167446 NCBI chr 8:84,908,755...84,911,703
Ensembl chr 8:84,908,560...84,922,915
JBrowse link
G Dnm1l dynamin 1-like multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNM1L mRNA CTD PMID:19167446 NCBI chr16:16,312,228...16,359,038
Ensembl chr16:16,312,230...16,358,959
JBrowse link
G Dnmt1 DNA methyltransferase (cytosine-5) 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNMT1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DNMT1 mRNA
Coumestrol results in increased expression of DNMT1 mRNA
CTD PMID:19167446 NCBI chr 9:20,907,206...20,959,888
Ensembl chr 9:20,907,209...20,959,888
JBrowse link
G Dock8 dedicator of cytokinesis 8 decreases expression ISO Coumestrol results in decreased expression of DOCK8 mRNA CTD PMID:19167446 NCBI chr19:24,999,321...25,202,432
Ensembl chr19:24,999,534...25,202,432
JBrowse link
G Donson downstream neighbor of SON increases expression
multiple interactions
ISO Coumestrol results in increased expression of DONSON mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DONSON mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DONSON mRNA
CTD PMID:19167446 NCBI chr16:91,666,856...91,688,932
Ensembl chr16:91,676,808...91,688,770
JBrowse link
G Dop1b DOP1 leucine zipper like protein B decreases expression ISO Coumestrol results in decreased expression of DOP1B mRNA CTD PMID:19167446 NCBI chr16:93,711,907...93,810,588
Ensembl chr16:93,711,904...93,810,590
JBrowse link
G Dpagt1 dolichyl-phosphate (UDP-N-acetylglucosamine) acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase) increases expression ISO Coumestrol results in increased expression of DPAGT1 mRNA CTD PMID:19167446 NCBI chr 9:44,325,857...44,333,895
Ensembl chr 9:44,326,019...44,333,900
JBrowse link
G Dpm2 dolichol-phosphate (beta-D) mannosyltransferase 2 increases expression ISO Coumestrol results in increased expression of DPM2 mRNA CTD PMID:19167446 NCBI chr 2:32,570,858...32,573,571
Ensembl chr 2:32,570,858...32,573,579
JBrowse link
G Dpy19l1 dpy-19-like 1 (C. elegans) increases expression ISO Coumestrol results in increased expression of DPY19L1 mRNA CTD PMID:19167446 NCBI chr 9:24,411,778...24,503,140
Ensembl chr 9:24,411,776...24,503,140
JBrowse link
G Dsc2 desmocollin 2 decreases expression ISO Coumestrol results in decreased expression of DSC2 mRNA CTD PMID:19167446 NCBI chr18:20,030,633...20,059,554
Ensembl chr18:20,030,633...20,059,554
JBrowse link
G Dscc1 DNA replication and sister chromatid cohesion 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DSCC1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DSCC1 mRNA
Coumestrol results in increased expression of DSCC1 mRNA
CTD PMID:19167446 NCBI chr15:55,076,101...55,090,491
Ensembl chr15:55,076,099...55,090,491
JBrowse link
G Dsn1 DSN1 homolog, MIS12 kinetochore complex component multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DSN1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DSN1 mRNA
Coumestrol results in increased expression of DSN1 mRNA
CTD PMID:19167446 NCBI chr 2:156,995,062...157,007,075
Ensembl chr 2:156,995,265...157,007,154
JBrowse link
G Dtna dystrobrevin alpha decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of DTNA mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DTNA mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of DTNA mRNA
CTD PMID:19167446 NCBI chr18:23,310,006...23,659,719
Ensembl chr18:23,415,135...23,659,715
JBrowse link
G Dusp1 dual specificity phosphatase 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DUSP1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of DUSP1 mRNA CTD PMID:19167446 NCBI chr17:26,505,591...26,508,472
Ensembl chr17:26,505,590...26,562,128
JBrowse link
G Dusp10 dual specificity phosphatase 10 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of DUSP10 mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of DUSP10 mRNA
CTD PMID:19167446 NCBI chr 1:184,034,381...184,075,636
Ensembl chr 1:184,013,302...184,075,636
JBrowse link
G Dusp22 dual specificity phosphatase 22 decreases expression ISO Coumestrol results in decreased expression of DUSP22 mRNA CTD PMID:19167446 NCBI chr13:30,660,059...30,711,232
Ensembl chr13:30,659,999...30,711,231
JBrowse link
G Dut deoxyuridine triphosphatase multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DUT mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DUT mRNA
Coumestrol results in increased expression of DUT mRNA
CTD PMID:19167446 NCBI chr 2:125,247,248...125,259,049
Ensembl chr 2:125,247,190...125,258,608
JBrowse link
G Dync1li1 dynein cytoplasmic 1 light intermediate chain 1 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of DYNC1LI1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DYNC1LI1 mRNA
CTD PMID:19167446 NCBI chr 9:114,688,831...114,723,788
Ensembl chr 9:114,688,790...114,724,302
JBrowse link
G Dynlt3 dynein light chain Tctex-type 3 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of DYNLT3 mRNA CTD PMID:19167446 NCBI chr  X:9,654,270...9,662,983
Ensembl chr  X:9,654,267...9,663,003
JBrowse link
G E2f1 E2F transcription factor 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of E2F1 mRNA CTD PMID:19167446 NCBI chr 2:154,559,400...154,569,892
Ensembl chr 2:154,559,407...154,569,892
JBrowse link
G E2f2 E2F transcription factor 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of E2F2 mRNA
Coumestrol results in increased expression of E2F2 mRNA
CTD PMID:19167446 NCBI chr 4:136,172,274...136,196,057
Ensembl chr 4:136,172,394...136,196,057
JBrowse link
G E2f5 E2F transcription factor 5 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of E2F5 mRNA
Coumestrol results in decreased expression of E2F5 mRNA
CTD PMID:19167446 NCBI chr 3:14,578,602...14,606,309
Ensembl chr 3:14,578,641...14,606,309
JBrowse link
G E2f7 E2F transcription factor 7 increases expression
multiple interactions
ISO Coumestrol results in increased expression of E2F7 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F7 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of E2F7 mRNA
CTD PMID:19167446 NCBI chr10:110,745,439...110,787,384
Ensembl chr10:110,745,439...110,787,384
JBrowse link
G E2f8 E2F transcription factor 8 increases expression
multiple interactions
ISO Coumestrol results in increased expression of E2F8 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F8 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of E2F8 mRNA
CTD PMID:19167446 NCBI chr 7:48,866,429...48,882,073
Ensembl chr 7:48,866,429...48,881,596
JBrowse link
G Ebp phenylalkylamine Ca2+ antagonist (emopamil) binding protein increases expression
multiple interactions
ISO Coumestrol results in increased expression of EBP mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EBP mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of EBP mRNA
CTD PMID:19167446 NCBI chr  X:8,185,329...8,193,512
Ensembl chr  X:8,185,329...8,193,512
JBrowse link
G Ect2 ect2 oncogene multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ECT2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ECT2 mRNA
Coumestrol results in increased expression of ECT2 mRNA
CTD PMID:19167446 NCBI chr 3:27,097,222...27,154,253
Ensembl chr 3:27,097,222...27,153,878
JBrowse link
G Edem3 ER degradation enhancer, mannosidase alpha-like 3 decreases expression ISO Coumestrol results in decreased expression of EDEM3 mRNA CTD PMID:19167446 NCBI chr 1:151,755,344...151,822,328
Ensembl chr 1:151,755,371...151,822,051
JBrowse link
G Edil3 EGF-like repeats and discoidin I-like domains 3 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EDIL3 mRNA CTD PMID:19167446 NCBI chr13:88,821,472...89,323,225
Ensembl chr13:88,821,472...89,323,223
JBrowse link
G Edn1 endothelin 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with resveratrol] results in decreased expression of EDN1 mRNA
Coumestrol results in decreased expression of EDN1 mRNA
CTD PMID:19167446 NCBI chr13:42,301,476...42,307,990
Ensembl chr13:42,301,476...42,307,990
JBrowse link
G Eed embryonic ectoderm development increases expression
multiple interactions
ISO Coumestrol results in increased expression of EED mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EED mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of EED mRNA
CTD PMID:19167446 NCBI chr 7:89,954,654...89,980,976
Ensembl chr 7:89,954,654...89,980,983
JBrowse link
G Eef1a1 eukaryotic translation elongation factor 1 alpha 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EEF1A1 mRNA CTD PMID:19167446 NCBI chr 9:78,478,453...78,481,724
Ensembl chr 9:78,478,449...78,489,151
JBrowse link
G Efemp1 epidermal growth factor-containing fibulin-like extracellular matrix protein 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFEMP1 mRNA CTD PMID:19167446 NCBI chr11:28,853,154...28,926,743
Ensembl chr11:28,853,204...28,926,743
JBrowse link
G Efhd1 EF hand domain containing 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFHD1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of EFHD1 mRNA
Coumestrol results in decreased expression of EFHD1 mRNA
CTD PMID:19167446 NCBI chr 1:87,264,353...87,310,841
Ensembl chr 1:87,264,363...87,310,839
JBrowse link
G Efna1 ephrin A1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFNA1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of EFNA1 mRNA
Coumestrol results in decreased expression of EFNA1 mRNA
CTD PMID:19167446 NCBI chr 3:89,271,730...89,280,951
Ensembl chr 3:89,271,733...89,281,142
JBrowse link
G Efnb2 ephrin B2 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFNB2 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of EFNB2 mRNA
Coumestrol results in decreased expression of EFNB2 mRNA
CTD PMID:19167446 NCBI chr 8:8,617,235...8,661,242
Ensembl chr 8:8,617,434...8,661,242
JBrowse link
G Efnb3 ephrin B3 decreases expression ISO Coumestrol results in decreased expression of EFNB3 mRNA CTD PMID:19167446 NCBI chr11:69,554,092...69,561,150
Ensembl chr11:69,554,092...69,560,205
JBrowse link
G Eftud2 elongation factor Tu GTP binding domain containing 2 increases expression ISO Coumestrol results in increased expression of EFTUD2 mRNA CTD PMID:19167446 NCBI chr11:102,838,472...102,880,984
Ensembl chr11:102,838,473...102,880,985
JBrowse link
G Egr1 early growth response 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EGR1 mRNA CTD PMID:19167446 NCBI chr18:34,861,207...34,864,956
Ensembl chr18:34,859,823...34,864,984
JBrowse link
G Egr3 early growth response 3 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EGR3 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of EGR3 mRNA CTD PMID:19167446 NCBI chr14:70,077,317...70,082,613
Ensembl chr14:70,077,203...70,082,614
JBrowse link
G Ehmt1 euchromatic histone methyltransferase 1 decreases expression ISO Coumestrol results in decreased expression of EHMT1 mRNA CTD PMID:19167446 NCBI chr 2:24,790,769...24,919,643
Ensembl chr 2:24,789,928...24,919,614
JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 decreases expression ISO Coumestrol results in decreased expression of EIF2AK3 mRNA CTD PMID:19167446 NCBI chr 6:70,844,484...70,905,241
Ensembl chr 6:70,844,515...70,905,245
JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2, subunit 1 alpha increases expression ISO Coumestrol results in increased expression of EIF2S1 mRNA CTD PMID:19167446 NCBI chr12:78,862,072...78,887,010
Ensembl chr12:78,861,819...78,887,010
JBrowse link
G Eif4ebp2 eukaryotic translation initiation factor 4E binding protein 2 increases expression ISO Coumestrol results in increased expression of EIF4EBP2 mRNA CTD PMID:19167446 NCBI chr10:61,428,491...61,452,790
Ensembl chr10:61,428,491...61,452,661
JBrowse link
G Eif4g3 eukaryotic translation initiation factor 4 gamma, 3 decreases expression ISO Coumestrol results in decreased expression of EIF4G3 mRNA CTD PMID:19167446 NCBI chr 4:137,991,779...138,207,086
Ensembl chr 4:137,993,022...138,208,508
JBrowse link
G Elapor1 endosome-lysosome associated apoptosis and autophagy regulator 1 multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in decreased expression of ELAPOR1 mRNA CTD PMID:19167446 NCBI chr 3:108,455,679...108,536,745
Ensembl chr 3:108,455,694...108,536,536
JBrowse link
G Elf5 E74-like factor 5 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ELF5 mRNA CTD PMID:19167446 NCBI chr 2:103,412,098...103,450,989
Ensembl chr 2:103,411,688...103,450,989
JBrowse link
G Elk1 ELK1, member of ETS oncogene family multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELK1 mRNA CTD PMID:19167446 NCBI chr  X:20,933,395...20,950,608
Ensembl chr  X:20,933,395...20,950,608
JBrowse link
G Elk3 ELK3, member of ETS oncogene family decreases expression ISO Coumestrol results in decreased expression of ELK3 mRNA CTD PMID:19167446 NCBI chr10:93,247,415...93,311,159
Ensembl chr10:93,247,414...93,311,135
JBrowse link
G Elmo2 engulfment and cell motility 2 decreases expression ISO Coumestrol results in decreased expression of ELMO2 mRNA CTD PMID:19167446 NCBI chr 2:165,288,031...165,326,479
Ensembl chr 2:165,288,031...165,326,479
JBrowse link
G Elovl2 elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ELOVL2 mRNA
Coumestrol results in increased expression of ELOVL2 mRNA
CTD PMID:19167446 NCBI chr13:41,182,382...41,220,403
Ensembl chr13:41,182,381...41,220,405
JBrowse link
G Elovl5 ELOVL family member 5, elongation of long chain fatty acids (yeast) increases expression
multiple interactions
ISO Coumestrol results in increased expression of ELOVL5 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of ELOVL5 mRNA
CTD PMID:19167446 NCBI chr 9:77,917,365...77,984,519
Ensembl chr 9:77,917,364...77,984,519
JBrowse link
G Elovl6 ELOVL family member 6, elongation of long chain fatty acids (yeast) multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL6 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ELOVL6 mRNA
Coumestrol results in increased expression of ELOVL6 mRNA
CTD PMID:19167446 NCBI chr 3:129,532,386...129,638,495
Ensembl chr 3:129,532,355...129,638,495
JBrowse link
G Elovl7 ELOVL family member 7, elongation of long chain fatty acids (yeast) multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL7 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ELOVL7 mRNA
Coumestrol results in increased expression of ELOVL7 mRNA
CTD PMID:19167446 NCBI chr13:108,214,326...108,287,109
Ensembl chr13:108,214,404...108,285,683
JBrowse link
G Elp5 elongator acetyltransferase complex subunit 5 multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of ELP5 mRNA
Coumestrol results in increased expression of ELP5 mRNA
CTD PMID:19167446 NCBI chr11:69,968,224...69,981,447
Ensembl chr11:69,968,222...69,982,517
JBrowse link
G Elp6 elongator acetyltransferase complex subunit 6 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELP6 mRNA
Coumestrol results in increased expression of ELP6 mRNA
CTD PMID:19167446 NCBI chr 9:110,304,398...110,322,102
Ensembl chr 9:110,305,173...110,322,102
JBrowse link
G Emc9 ER membrane protein complex subunit 9 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EMC9 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of EMC9 mRNA
Coumestrol results in increased expression of EMC9 mRNA
CTD PMID:19167446 NCBI chr14:55,581,519...55,585,375
Ensembl chr14:55,581,516...55,585,302
JBrowse link
G Emd emerin increases expression ISO Coumestrol results in increased expression of EMD mRNA CTD PMID:19167446 NCBI chr  X:74,254,674...74,261,563
Ensembl chr  X:74,261,032...74,261,374
Ensembl chr  X:74,261,032...74,261,374
JBrowse link
G Eme1 essential meiotic structure-specific endonuclease 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EME1 mRNA CTD PMID:19167446 NCBI chr11:94,644,972...94,653,836
Ensembl chr11:94,644,996...94,653,964
JBrowse link
G Enc1 ectodermal-neural cortex 1 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of ENC1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ENC1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of ENC1 mRNA
CTD PMID:19167446 NCBI chr13:97,241,105...97,253,040
Ensembl chr13:97,241,105...97,253,034
JBrowse link
G Endod1 endonuclease domain containing 1 increases expression
multiple interactions
ISO Coumestrol results in increased expression of ENDOD1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ENDOD1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ENDOD1 mRNA
CTD PMID:19167446 NCBI chr 9:14,353,990...14,381,242
Ensembl chr 9:14,353,990...14,381,507
JBrowse link
G Entpd2 ectonucleoside triphosphate diphosphohydrolase 2 decreases expression ISO Coumestrol results in decreased expression of ENTPD2 mRNA CTD PMID:19167446 NCBI chr 2:25,395,874...25,401,323
Ensembl chr 2:25,395,874...25,401,321
JBrowse link
G Entpd4 ectonucleoside triphosphate diphosphohydrolase 4 decreases expression ISO Coumestrol results in decreased expression of ENTPD4 mRNA CTD PMID:19167446 NCBI chr14:69,337,151...69,366,742
Ensembl chr14:69,337,174...69,367,270
JBrowse link
G Epb41l2 erythrocyte membrane protein band 4.1 like 2 decreases expression ISO Coumestrol results in decreased expression of EPB41L2 mRNA CTD PMID:19167446 NCBI chr10:25,359,782...25,523,519
Ensembl chr10:25,359,798...25,523,519
JBrowse link
G Epb41l5 erythrocyte membrane protein band 4.1 like 5 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EPB41L5 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of EPB41L5 mRNA
Coumestrol results in decreased expression of EPB41L5 mRNA
CTD PMID:19167446 NCBI chr 1:119,545,032...119,649,096
Ensembl chr 1:119,545,037...119,649,000
JBrowse link
G Epha4 Eph receptor A4 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EPHA4 mRNA CTD PMID:19167446 NCBI chr 1:77,367,182...77,515,107
Ensembl chr 1:77,367,185...77,515,088
JBrowse link
G Eps15l1 epidermal growth factor receptor pathway substrate 15-like 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EPS15L1 mRNA
Coumestrol results in increased expression of EPS15L1 mRNA
CTD PMID:19167446 NCBI chr 8:72,340,990...72,421,576
Ensembl chr 8:72,340,999...72,421,460
JBrowse link
G Erbb2 erb-b2 receptor tyrosine kinase 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of ERBB2 mRNA CTD PMID:19167446 NCBI chr11:98,412,484...98,437,716
Ensembl chr11:98,412,470...98,437,716
JBrowse link
G Erbb3 erb-b2 receptor tyrosine kinase 3 decreases expression ISO Coumestrol results in decreased expression of ERBB3 mRNA CTD PMID:19167446 NCBI chr10:128,567,523...128,589,635
Ensembl chr10:128,567,523...128,589,652
JBrowse link
G Erbb4 erb-b2 receptor tyrosine kinase 4 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of ERBB4 mRNA CTD PMID:19167446 NCBI chr 1:68,031,884...69,108,576
Ensembl chr 1:68,032,186...69,108,059
JBrowse link
G Ercc6l excision repair cross-complementing rodent repair deficiency complementation group 6 like increases expression
multiple interactions
ISO Coumestrol results in increased expression of ERCC6L mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ERCC6L mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ERCC6L mRNA
CTD PMID:19167446 NCBI chr  X:102,142,820...102,157,091
Ensembl chr  X:102,141,716...102,157,091
JBrowse link
G Eri2 exoribonuclease 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ERI2 mRNA CTD PMID:19167446 NCBI chr 7:119,783,826...119,794,058
Ensembl chr 7:119,768,679...119,794,058
JBrowse link
G Errfi1 ERBB receptor feedback inhibitor 1 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of ERRFI1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ERRFI1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of ERRFI1 mRNA
CTD PMID:19167446 NCBI chr 4:150,853,796...150,868,889
Ensembl chr 4:150,853,919...150,868,892
JBrowse link
G Esco2 establishment of sister chromatid cohesion N-acetyltransferase 2 increases expression ISO Coumestrol results in increased expression of ESCO2 mRNA CTD PMID:19167446 NCBI chr14:65,819,027...65,833,969
Ensembl chr14:65,819,038...65,833,994
JBrowse link
G Espl1 extra spindle pole bodies 1, separase multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ESPL1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ESPL1 mRNA
Coumestrol results in increased expression of ESPL1 mRNA
CTD PMID:19167446 NCBI chr15:102,296,254...102,324,357
Ensembl chr15:102,296,266...102,324,357
JBrowse link
G Esr1 estrogen receptor 1 (alpha) multiple interactions
affects response to substance
increases activity
affects binding
decreases expression
ISO
EXP
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane inhibits the reaction [Coumestrol binds to ESR1 protein modified form]; 4,4'-hexafluorisopropylidene diphenol inhibits the reaction [Coumestrol binds to ESR1 protein modified form]; [Coumestrol binds to ESR1 protein] which results in increased activity of ALPL protein; [Coumestrol co-treated with ESR1 protein] results in increased expression of ADRA2A mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of ANLN mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of ANP32E mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of ASPM mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of AURKA mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of BIN3 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CCNA2 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CDCA3 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CDKN2C mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CDKN3 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CENPF mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CLCC1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CTNNAL1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CXCL12 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of DEPDC1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of DEPDC1B mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of DHRS2 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of EXOSC9 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of FABP5 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of FCMR mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of FHL1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of GAL mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of GPSM2 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of GREB1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of GTSE1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of HMGB2 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of HMMR mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of IGFBP4 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of IL17RB mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of IL20 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of IRS1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of KCNK5 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of KIF14 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of KIF15 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of KIF18A mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of KIF20A mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of MKI67 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of MYB mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of MYC mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of NCAPG mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of NEK2 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of NPY1R mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of NUSAP1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of PDLIM3 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of PDZK1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of PIF1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of PKIB mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of PLK1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of RACGAP1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of RASGRP1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of RERG mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of SLC26A2 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of SPC25 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of ST8SIA6 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of STC2 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of TFF1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of TMPRSS3 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of TOP2A mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of TRAF4 mRNA; Benzo(a)pyrene inhibits the reaction [Coumestrol binds to ESR1 protein modified form]; CCND1 protein promotes the reaction [Coumestrol results in increased activity of ESR1 protein]; Coumestrol binds to and results in increased activity of ESR1 protein; Coumestrol inhibits the reaction [16 alpha-iodoestradiol binds to ESR1 protein]; Coumestrol inhibits the reaction [Estradiol binds to ESR1 protein]; Coumestrol promotes the reaction [NCOA2 protein binds to ESR1 protein]; Diethylstilbestrol inhibits the reaction [Coumestrol binds to ESR1 protein]; ESR1 protein inhibits the reaction [Coumestrol results in increased expression of CCN5 mRNA]; ESR1 protein inhibits the reaction [Coumestrol results in increased expression of CXCL12 mRNA]; ESR1 protein inhibits the reaction [Coumestrol results in increased expression of PGR mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ADRA2A mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ANLN mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ANP32E mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ASPM mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of AURKA mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of BIN3 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CCNA2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CDCA3 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CENPF mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CLCC1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CTNNAL1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CXCL12 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of DEPDC1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of DEPDC1B mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of DHRS2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of EXOSC9 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of FABP5 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of FCMR mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of FHL1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of GAL mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of GPSM2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of GREB1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of GTSE1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of HMGB2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of HMMR mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of IGFBP4 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of IL17RB mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of IL20 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of IRS1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of KCNK5 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of KIF18A mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of MKI67 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of MYB mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of MYC mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of NCAPG mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of NEK2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of NPY1R mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of NUSAP1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of PDLIM3 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of PDZK1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of PIF1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of PKIB mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of PLK1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of RACGAP1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of RASGRP1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of RERG mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of SLC26A2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of SPC25 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ST8SIA6 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of STC2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of TFF1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of TMPRSS3 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of TRAF4 mRNA]; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CDKN2C mRNA]; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CDKN3 mRNA]; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of KIF14 mRNA]; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of KIF15 mRNA]; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of KIF20A mRNA]; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of TOP2A mRNA]; Estradiol inhibits the reaction [Coumestrol binds to ESR1 protein]; Fulvestrant inhibits the reaction [[Coumestrol binds to ESR1 protein] which results in increased activity of ALPL protein]; Fulvestrant inhibits the reaction [Coumestrol results in increased activity of ESR1 protein]; Tamoxifen inhibits the reaction [Coumestrol results in increased activity of ESR1 protein]; Tamoxifen promotes the reaction [Coumestrol results in increased activity of ESR1 protein mutant form]; tetrabromobisphenol A inhibits the reaction [Coumestrol binds to ESR1 protein modified form]; tetrachlorodian inhibits the reaction [Coumestrol binds to ESR1 protein modified form]
ESR1 protein affects the susceptibility to Coumestrol
Coumestrol results in decreased expression of ESR1 protein
Coumestrol binds to ESR1 protein; Coumestrol binds to ESR1 protein modified form
CTD PMID:9048584, PMID:9751507, PMID:10397250, PMID:11162928, PMID:11518614, PMID:11867264, PMID:12650720, PMID:12765243, PMID:15084758, PMID:15876408, PMID:16118406, PMID:16328721, PMID:16566672, PMID:17174995, PMID:17275032, PMID:18310284, PMID:19400946, PMID:19913605, PMID:22562034, PMID:23384675, PMID:28396216, PMID:29152682, PMID:29162470, PMID:30143207 NCBI chr10:4,611,989...5,005,633
Ensembl chr10:4,611,593...5,005,614
JBrowse link
G Esr2 estrogen receptor 2 (beta) multiple interactions
increases expression
affects response to substance
affects binding
increases activity
ISO
EXP
Coumestrol binds to and results in increased activity of ESR2 protein; Coumestrol inhibits the reaction [Estradiol binds to ESR2 protein]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ADRA2A mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ANLN mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ANP32E mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ASPM mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of AURKA mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of BIN3 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CCNA2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CDCA3 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CENPF mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CLCC1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CTNNAL1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CXCL12 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of DEPDC1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of DEPDC1B mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of DHRS2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of EXOSC9 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of FABP5 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of FCMR mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of FHL1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of GAL mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of GPSM2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of GREB1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of GTSE1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of HMGB2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of HMMR mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of IGFBP4 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of IL17RB mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of IL20 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of IRS1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of KCNK5 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of KIF18A mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of MKI67 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of MYB mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of MYC mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of NCAPG mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of NEK2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of NPY1R mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of NUSAP1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of PDLIM3 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of PDZK1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of PIF1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of PKIB mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of PLK1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of RACGAP1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of RASGRP1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of RERG mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of SLC26A2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of SPC25 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ST8SIA6 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of STC2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of TFF1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of TMPRSS3 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of TRAF4 mRNA]; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CDKN2C mRNA]; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CDKN3 mRNA]; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of KIF14 mRNA]; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of KIF15 mRNA]; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of KIF20A mRNA]; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of TOP2A mRNA]
Coumestrol results in increased expression of ESR2 protein; Coumestrol results in increased expression of ESR2 protein alternative form
ESR2 protein affects the susceptibility to Coumestrol
ESR2 protein affects the reaction [Coumestrol results in increased expression of SOD2 protein]
Coumestrol binds to ESR2 protein
Coumestrol inhibits the reaction [16 alpha-iodoestradiol binds to ESR2 protein]; Coumestrol inhibits the reaction [Estradiol binds to ESR2 protein alternative form]
Coumestrol results in increased activity of ESR2 protein
CTD PMID:9048584, PMID:9492041, PMID:9751507, PMID:11518614, PMID:12224631, PMID:12765243, PMID:15084758, PMID:16118406, PMID:16566672, PMID:17275032, PMID:18310284, PMID:19913605, PMID:21708076, PMID:23526725, PMID:27634370 NCBI chr12:76,120,419...76,177,259
Ensembl chr12:76,120,419...76,177,259
JBrowse link
G Esyt2 extended synaptotagmin-like protein 2 decreases expression ISO Coumestrol results in decreased expression of ESYT2 mRNA CTD PMID:19167446 NCBI chr12:116,279,283...116,390,935
Ensembl chr12:116,281,196...116,391,050
JBrowse link
G Etnk1 ethanolamine kinase 1 decreases expression ISO Coumestrol results in decreased expression of ETNK1 mRNA CTD PMID:19167446 NCBI chr 6:143,166,866...143,208,546
Ensembl chr 6:143,167,221...143,232,307
JBrowse link
G Evi5 ecotropic viral integration site 5 decreases expression ISO Coumestrol results in decreased expression of EVI5 mRNA CTD PMID:19167446 NCBI chr 5:107,744,795...107,875,107
Ensembl chr 5:107,744,795...107,875,107
JBrowse link
G Exo1 exonuclease 1 increases expression
multiple interactions
ISO Coumestrol results in increased expression of EXO1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EXO1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of EXO1 mRNA
CTD PMID:19167446 NCBI chr 1:175,880,768...175,911,396
Ensembl chr 1:175,880,581...175,913,489
JBrowse link
G Exoc2 exocyst complex component 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EXOC2 mRNA CTD PMID:19167446 NCBI chr13:30,789,516...30,974,096
Ensembl chr13:30,813,919...30,974,093
JBrowse link
G Exosc2 exosome component 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of EXOSC2 mRNA CTD PMID:19167446 NCBI chr 2:31,670,715...31,681,352
Ensembl chr 2:31,670,715...31,681,349
JBrowse link
G Exosc3 exosome component 3 increases expression ISO Coumestrol results in increased expression of EXOSC3 mRNA CTD PMID:19167446 NCBI chr 4:45,316,613...45,320,616
Ensembl chr 4:45,316,613...45,342,732
JBrowse link
G Exosc8 exosome component 8 increases expression ISO Coumestrol results in increased expression of EXOSC8 mRNA CTD PMID:19167446 NCBI chr 3:54,728,679...54,735,364
Ensembl chr 3:54,728,678...54,735,393
JBrowse link
G Exosc9 exosome component 9 multiple interactions ISO [Coumestrol co-treated with ESR1 protein] results in increased expression of EXOSC9 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of EXOSC9 mRNA] CTD PMID:18310284 NCBI chr 3:36,552,606...36,565,727
Ensembl chr 3:36,552,606...36,565,727
JBrowse link
G Ext1 exostosin glycosyltransferase 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EXT1 mRNA
Coumestrol results in decreased expression of EXT1 mRNA
CTD PMID:19167446 NCBI chr15:53,068,261...53,346,183
Ensembl chr15:53,064,038...53,346,159
JBrowse link
G Ezh2 enhancer of zeste 2 polycomb repressive complex 2 subunit increases expression
multiple interactions
ISO Coumestrol results in increased expression of EZH2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EZH2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of EZH2 mRNA
CTD PMID:19167446 NCBI chr 6:47,530,274...47,595,270
Ensembl chr 6:47,530,139...47,595,341
JBrowse link
G Ezr ezrin multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EZR mRNA CTD PMID:19167446 NCBI chr17:6,738,131...6,782,780
Ensembl chr17:6,738,041...6,782,784
JBrowse link
G F2r coagulation factor II (thrombin) receptor decreases expression ISO Coumestrol results in decreased expression of F2R mRNA CTD PMID:19167446 NCBI chr13:95,601,780...95,618,466
Ensembl chr13:95,601,803...95,618,487
JBrowse link
G F2rl1 coagulation factor II (thrombin) receptor-like 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of F2RL1 mRNA
Coumestrol results in decreased expression of F2RL1 mRNA
CTD PMID:19167446 NCBI chr13:95,511,718...95,525,240
Ensembl chr13:95,511,732...95,525,227
JBrowse link
G Fabp5 fatty acid binding protein 5, epidermal multiple interactions ISO [Coumestrol co-treated with ESR1 protein] results in increased expression of FABP5 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of FABP5 mRNA] CTD PMID:18310284 NCBI chr 3:10,012,585...10,016,610
Ensembl chr 3:10,012,548...10,016,607
JBrowse link
G Fads1 fatty acid desaturase 1 increases expression
multiple interactions
ISO Coumestrol results in increased expression of FADS1 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of FADS1 mRNA
CTD PMID:19167446 NCBI chr19:10,182,877...10,196,874
Ensembl chr19:10,182,888...10,196,877
JBrowse link
G Fah fumarylacetoacetate hydrolase increases expression ISO Coumestrol results in increased expression of FAH mRNA CTD PMID:19167446 NCBI chr 7:84,585,159...84,605,942
Ensembl chr 7:84,585,159...84,606,722
JBrowse link
G Fam107b family with sequence similarity 107, member B multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM107B mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of FAM107B mRNA
Coumestrol results in decreased expression of FAM107B mRNA
CTD PMID:19167446 NCBI chr 2:3,704,812...3,782,142
Ensembl chr 2:3,570,488...3,782,142
JBrowse link
G Fam110b family with sequence similarity 110, member B multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM110B mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of FAM110B mRNA
Coumestrol results in decreased expression of FAM110B mRNA
CTD PMID:19167446 NCBI chr 4:5,644,009...5,801,101
Ensembl chr 4:5,644,090...6,108,223
JBrowse link
G Fam110c family with sequence similarity 110, member C decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of FAM110C mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of FAM110C mRNA
CTD PMID:19167446 NCBI chr12:31,073,968...31,079,940
Ensembl chr12:31,073,861...31,080,251
JBrowse link
G Fam111a family with sequence similarity 111, member A multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FAM111A mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of FAM111A mRNA
Coumestrol results in increased expression of FAM111A mRNA
CTD PMID:19167446 NCBI chr19:12,573,510...12,589,769
Ensembl chr19:12,545,740...12,589,768
JBrowse link
G Fam122b family with sequence similarity 122, member B increases expression ISO Coumestrol results in increased expression of FAM122B mRNA CTD PMID:19167446 NCBI chr  X:53,243,415...53,269,850
Ensembl chr  X:53,243,415...53,269,805
JBrowse link
G Fam126b family with sequence similarity 126, member B decreases expression ISO Coumestrol results in decreased expression of FAM126B mRNA CTD PMID:19167446 NCBI chr 1:58,522,806...58,586,333
Ensembl chr 1:58,522,806...58,586,323
JBrowse link
G Fam149b family with sequence similarity 149, member B multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM149B1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of FAM149B1 mRNA
Coumestrol results in decreased expression of FAM149B1 mRNA
CTD PMID:19167446 NCBI chr14:20,348,158...20,383,491
Ensembl chr14:20,348,162...20,383,491
JBrowse link
G Fam161b family with sequence similarity 161, member B decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of FAM161B mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of FAM161B mRNA
CTD PMID:19167446 NCBI chr12:84,345,309...84,361,860
Ensembl chr12:84,345,309...84,361,833
JBrowse link
G Fam169a family with sequence similarity 169, member A decreases expression ISO Coumestrol results in decreased expression of FAM169A mRNA CTD PMID:19167446 NCBI chr13:97,067,287...97,130,293
Ensembl chr13:97,067,286...97,131,013
JBrowse link
G Fam171b family with sequence similarity 171, member B multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of FAM171B mRNA CTD PMID:19167446 NCBI chr 2:83,812,563...83,883,534
Ensembl chr 2:83,812,636...83,883,486
JBrowse link
G Fam174b family with sequence similarity 174, member B decreases expression ISO Coumestrol results in decreased expression of FAM174B mRNA CTD PMID:19167446 NCBI chr 7:73,740,307...73,776,919
Ensembl chr 7:73,740,302...73,776,919
JBrowse link
G Fam189a2 family with sequence similarity 189, member A2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM189A2 mRNA CTD PMID:19167446 NCBI chr19:23,972,750...24,031,436
Ensembl chr19:23,972,750...24,031,019
JBrowse link
G Fam210b family with sequence similarity 210, member B decreases expression ISO Coumestrol results in decreased expression of FAM210B mRNA CTD PMID:19167446 NCBI chr 2:172,345,570...172,355,749
Ensembl chr 2:172,345,565...172,355,749
JBrowse link
G Fam214a family with sequence similarity 214, member A decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of FAM214A mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM214A mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of FAM214A mRNA
CTD PMID:19167446 NCBI chr 9:74,952,867...75,032,468
Ensembl chr 9:74,952,884...75,032,468
JBrowse link
G Fam216a family with sequence similarity 216, member A increases expression ISO Coumestrol results in increased expression of FAM216A mRNA CTD PMID:19167446 NCBI chr 5:122,364,584...122,372,342
Ensembl chr 5:122,364,580...122,372,364
JBrowse link
G Fam222b family with sequence similarity 222, member B decreases expression ISO Coumestrol results in decreased expression of FAM222B mRNA CTD PMID:19167446 NCBI chr11:78,094,690...78,157,339
Ensembl chr11:78,094,660...78,156,700
JBrowse link
G Fam43a family with sequence similarity 43, member A multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM43A mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of FAM43A mRNA
Coumestrol results in decreased expression of FAM43A mRNA
CTD PMID:19167446 NCBI chr16:30,599,723...30,602,797
Ensembl chr16:30,599,723...30,602,797
JBrowse link
G Fanca Fanconi anemia, complementation group A multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of FANCA mRNA CTD PMID:19167446 NCBI chr 8:123,266,294...123,318,651
Ensembl chr 8:123,268,300...123,318,576
JBrowse link
G Fancd2 Fanconi anemia, complementation group D2 increases expression
multiple interactions
ISO Coumestrol results in increased expression of FANCD2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCD2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of FANCD2 mRNA
CTD PMID:19167446 NCBI chr 6:113,531,640...113,597,020
Ensembl chr 6:113,531,682...113,597,017
JBrowse link
G Fancg Fanconi anemia, complementation group G multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCG mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of FANCG mRNA
Coumestrol results in increased expression of FANCG mRNA
CTD PMID:19167446 NCBI chr 4:43,002,337...43,010,567
Ensembl chr 4:43,002,343...43,010,506
JBrowse link
G Fanci Fanconi anemia, complementation group I multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCI mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of FANCI mRNA
Coumestrol results in increased expression of FANCI mRNA
CTD PMID:19167446 NCBI chr 7:79,392,312...79,450,266
Ensembl chr 7:79,391,929...79,450,264
JBrowse link
G Fancl Fanconi anemia, complementation group L multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCL mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of FANCL mRNA CTD PMID:19167446 NCBI chr11:26,387,084...26,471,883
Ensembl chr11:26,386,135...26,471,876
JBrowse link
G Farsb phenylalanyl-tRNA synthetase, beta subunit increases expression ISO Coumestrol results in increased expression of FARSB mRNA CTD PMID:19167446 NCBI chr 1:78,417,958...78,488,897
Ensembl chr 1:78,417,975...78,488,897
JBrowse link
G Fblim1 filamin binding LIM protein 1 decreases expression ISO Coumestrol results in decreased expression of FBLIM1 mRNA CTD PMID:19167446 NCBI chr 4:141,576,062...141,606,052
Ensembl chr 4:141,576,062...141,606,096
JBrowse link
G Fbxl5 F-box and leucine-rich repeat protein 5 decreases expression ISO Coumestrol results in decreased expression of FBXL5 mRNA CTD PMID:19167446 NCBI chr 5:43,744,618...43,782,149
Ensembl chr 5:43,744,615...43,821,638
JBrowse link
G Fbxo38 F-box protein 38 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FBXO38 mRNA CTD PMID:19167446 NCBI chr18:62,504,059...62,548,863
Ensembl chr18:62,504,155...62,548,695
JBrowse link
G Fbxo5 F-box protein 5 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FBXO5 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of FBXO5 mRNA
Coumestrol results in increased expression of FBXO5 mRNA
CTD PMID:19167446 NCBI chr10:5,799,158...5,805,465
Ensembl chr10:5,799,160...5,805,600
JBrowse link
G Fcf1 FCF1 rRNA processing protein increases expression ISO Coumestrol results in increased expression of FCF1 mRNA CTD PMID:19167446 NCBI chr12:84,970,930...84,983,303
Ensembl chr12:84,970,897...84,983,303
JBrowse link
G Fcmr Fc fragment of IgM receptor multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FCMR mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of FCMR mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of FCMR mRNA] CTD PMID:18310284, PMID:19167446 NCBI chr 1:130,865,777...130,880,790
Ensembl chr 1:130,865,669...130,880,791
JBrowse link
G Fdft1 farnesyl diphosphate farnesyl transferase 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FDFT1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of FDFT1 mRNA
Coumestrol results in increased expression of FDFT1 mRNA
CTD PMID:19167446 NCBI chr14:63,145,150...63,181,687
Ensembl chr14:63,145,150...63,179,578
JBrowse link
G Fdps farnesyl diphosphate synthetase multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of FDPS mRNA
Coumestrol results in increased expression of FDPS mRNA
CTD PMID:19167446 NCBI chr 3:89,093,588...89,101,967
Ensembl chr 3:89,093,588...89,101,959
JBrowse link
G Fen1 flap structure specific endonuclease 1 increases expression
multiple interactions
ISO Coumestrol results in increased expression of FEN1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FEN1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of FEN1 mRNA
CTD PMID:19167446 NCBI chr19:10,199,132...10,204,393
Ensembl chr19:10,199,132...10,204,169
JBrowse link
G Fermt2 fermitin family member 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FERMT2 mRNA CTD PMID:19167446 NCBI chr14:45,458,792...45,530,310
Ensembl chr14:45,458,795...45,530,118
JBrowse link
G Fgfr1 fibroblast growth factor receptor 1 decreases expression ISO Coumestrol results in decreased expression of FGFR1 mRNA CTD PMID:19167446 NCBI chr 8:25,518,759...25,575,718
Ensembl chr 8:25,513,654...25,575,718
JBrowse link
G Fh1 fumarate hydratase 1 increases expression ISO Coumestrol results in increased expression of FH mRNA CTD PMID:19167446 NCBI chr 1:175,601,378...175,625,635
Ensembl chr 1:175,600,374...175,625,635
JBrowse link
G Fhl1 four and a half LIM domains 1 multiple interactions ISO [Coumestrol co-treated with ESR1 protein] results in increased expression of FHL1 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of FHL1 mRNA] CTD PMID:18310284 NCBI chr  X:56,731,209...56,793,346
Ensembl chr  X:56,731,787...56,793,346
JBrowse link
G Fhl2 four and a half LIM domains 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of FHL2 mRNA
Coumestrol results in increased expression of FHL2 mRNA
CTD PMID:19167446 NCBI chr 1:43,123,071...43,198,343
Ensembl chr 1:43,123,074...43,196,984
JBrowse link
G Fibp fibroblast growth factor (acidic) intracellular binding protein multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FIBP mRNA CTD PMID:19167446 NCBI chr19:5,460,598...5,465,052
Ensembl chr19:5,460,615...5,465,051
JBrowse link
G Fignl1 fidgetin-like 1 increases expression
multiple interactions
ISO Coumestrol results in increased expression of FIGNL1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FIGNL1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of FIGNL1 mRNA
CTD PMID:19167446 NCBI chr11:11,800,288...11,808,983
Ensembl chr11:11,787,431...11,808,962
JBrowse link
G Filip1l filamin A interacting protein 1-like multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FILIP1L mRNA CTD PMID:19167446 NCBI chr16:57,353,277...57,572,804
Ensembl chr16:57,353,093...57,573,126
JBrowse link
G Fkbp11 FK506 binding protein 11 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FKBP11 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of FKBP11 mRNA
Coumestrol results in increased expression of FKBP11 mRNA
CTD PMID:19167446 NCBI chr15:98,724,368...98,728,198
Ensembl chr15:98,724,366...98,728,198
JBrowse link
G Fkbp4 FK506 binding protein 4 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FKBP4 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of FKBP4 mRNA
Coumestrol results in increased expression of FKBP4 mRNA
CTD PMID:19167446 NCBI chr 6:128,430,103...128,438,656
Ensembl chr 6:128,429,735...128,438,677
JBrowse link
G Fkbp5 FK506 binding protein 5 multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of FKBP5 mRNA
Coumestrol results in increased expression of FKBP5 mRNA
CTD PMID:19167446 NCBI chr17:28,398,753...28,486,149
Ensembl chr17:28,399,094...28,517,527
JBrowse link
G Fkbpl FK506 binding protein-like increases expression ISO Coumestrol results in increased expression of FKBPL mRNA CTD PMID:19167446 NCBI chr17:34,644,814...34,646,817
Ensembl chr17:34,644,764...34,646,324
JBrowse link
G Flcn folliculin decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of FLCN mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FLCN mRNA
CTD PMID:19167446 NCBI chr11:59,791,408...59,810,039
Ensembl chr11:59,791,408...59,810,016
JBrowse link
G Fmnl2 formin-like 2 decreases expression ISO Coumestrol results in decreased expression of FMNL2 mRNA CTD PMID:19167446 NCBI chr 2:52,857,717...53,134,202
Ensembl chr 2:52,857,860...53,133,804
JBrowse link
G Fnbp1 formin binding protein 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FNBP1 mRNA CTD PMID:19167446 NCBI chr 2:31,026,206...31,145,454
Ensembl chr 2:31,026,206...31,142,008
JBrowse link
G Fnbp1l formin binding protein 1-like multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FNBP1L mRNA
Coumestrol results in decreased expression of FNBP1L mRNA
CTD PMID:19167446 NCBI chr 3:122,538,719...122,619,714
Ensembl chr 3:122,538,719...122,619,715
JBrowse link
G Fndc3b fibronectin type III domain containing 3B decreases expression ISO Coumestrol results in decreased expression of FNDC3B mRNA CTD PMID:19167446 NCBI chr 3:27,416,135...27,711,307
Ensembl chr 3:27,416,162...27,711,307
JBrowse link
G Fos FBJ osteosarcoma oncogene multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FOS mRNA CTD PMID:19167446 NCBI chr12:85,473,890...85,477,274
Ensembl chr12:85,473,890...85,477,273
JBrowse link
G Foxd1 forkhead box D1 decreases expression ISO Coumestrol results in decreased expression of FOXD1 mRNA CTD PMID:19167446 NCBI chr13:98,354,245...98,356,705
Ensembl chr13:98,354,242...98,359,305
JBrowse link
G Foxm1 forkhead box M1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FOXM1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of FOXM1 mRNA
Coumestrol results in increased expression of FOXM1 mRNA
CTD PMID:19167446 NCBI chr 6:128,362,994...128,375,886
Ensembl chr 6:128,362,967...128,376,146
JBrowse link
G Foxo3 forkhead box O3 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FOXO3 mRNA
Coumestrol results in decreased expression of FOXO3 mRNA
CTD PMID:19167446 NCBI chr10:42,181,845...42,276,695
Ensembl chr10:42,181,841...42,276,755
JBrowse link
G Foxp2 forkhead box P2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FOXP2 mRNA CTD PMID:19167446 NCBI chr 6:14,901,349...15,441,977
Ensembl chr 6:14,901,349...15,441,977
JBrowse link
G Foxred2 FAD-dependent oxidoreductase domain containing 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of FOXRED2 mRNA CTD PMID:19167446 NCBI chr15:77,940,522...77,958,503
Ensembl chr15:77,940,522...77,956,722
JBrowse link
G Frmd3 FERM domain containing 3 decreases expression ISO Coumestrol results in decreased expression of FRMD3 mRNA CTD PMID:19167446 NCBI chr 4:74,013,228...74,202,214
Ensembl chr 4:74,013,442...74,202,214
JBrowse link
G Frmd6 FERM domain containing 6 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FRMD6 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of FRMD6 mRNA
Coumestrol results in decreased expression of FRMD6 mRNA
CTD PMID:19167446 NCBI chr12:70,825,456...70,902,234
Ensembl chr12:70,825,514...70,902,234
JBrowse link
G Fscn1 fascin actin-bundling protein 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FSCN1 mRNA CTD PMID:19167446 NCBI chr 5:142,960,355...142,973,189
Ensembl chr 5:142,960,343...142,973,185
JBrowse link
G Ftsj1 FtsJ RNA methyltransferase homolog 1 (E. coli) increases expression ISO Coumestrol results in increased expression of FTSJ1 mRNA CTD PMID:19167446 NCBI chr  X:8,238,668...8,252,406
Ensembl chr  X:8,238,668...8,252,406
JBrowse link
G Fuca1 fucosidase, alpha-L- 1, tissue multiple interactions
decreases expression
ISO [Coumestrol co-treated with resveratrol] results in decreased expression of FUCA1 mRNA
Coumestrol results in decreased expression of FUCA1 mRNA
CTD PMID:19167446 NCBI chr 4:135,920,726...135,940,300
Ensembl chr 4:135,920,735...135,940,311
JBrowse link
G Fyb2 FYN binding protein 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of FYB2 mRNA CTD PMID:19167446 NCBI chr 4:104,835,301...105,016,864
Ensembl chr 4:104,913,456...105,016,863
JBrowse link
G Fyco1 FYVE and coiled-coil domain containing 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FYCO1 mRNA
Coumestrol results in decreased expression of FYCO1 mRNA
CTD PMID:19167446 NCBI chr 9:123,789,500...123,851,899
Ensembl chr 9:123,789,500...123,851,899
JBrowse link
G Fzd2 frizzled class receptor 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of FZD2 mRNA CTD PMID:19167446 NCBI chr11:102,604,431...102,608,058
Ensembl chr11:102,604,396...102,608,058
JBrowse link
G G2e3 G2/M-phase specific E3 ubiquitin ligase multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of G2E3 mRNA
Coumestrol results in increased expression of G2E3 mRNA
CTD PMID:19167446 NCBI chr12:51,348,230...51,376,986
Ensembl chr12:51,348,061...51,376,986
JBrowse link
G G3bp2 GTPase activating protein (SH3 domain) binding protein 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of G3BP2 mRNA CTD PMID:19167446 NCBI chr 5:92,052,145...92,137,725
Ensembl chr 5:92,052,146...92,083,719
JBrowse link
G Gabpb2 GA repeat binding protein, beta 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GABPB2 mRNA
Coumestrol results in increased expression of GABPB2 mRNA
CTD PMID:19167446 NCBI chr 3:95,181,766...95,218,110
Ensembl chr 3:95,181,766...95,217,916
JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible 45 alpha decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of GADD45A mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GADD45A mRNA
CTD PMID:19167446 NCBI chr 6:67,035,096...67,037,407
Ensembl chr 6:67,035,096...67,037,457
JBrowse link
G Gadd45gip1 growth arrest and DNA-damage-inducible, gamma interacting protein 1 increases expression ISO Coumestrol results in increased expression of GADD45GIP1 mRNA CTD PMID:19167446 NCBI chr 8:84,832,282...84,835,482
Ensembl chr 8:84,831,522...84,835,482
JBrowse link
G Gal galanin and GMAP prepropeptide multiple interactions ISO [Coumestrol co-treated with ESR1 protein] results in increased expression of GAL mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of GAL mRNA] CTD PMID:18310284 NCBI chr19:3,409,915...3,414,544
Ensembl chr19:3,409,915...3,414,544
JBrowse link
G Galns galactosamine (N-acetyl)-6-sulfate sulfatase multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNS mRNA CTD PMID:19167446 NCBI chr 8:122,578,237...122,611,701
Ensembl chr 8:122,578,242...122,611,463
JBrowse link
G Galnt1 polypeptide N-acetylgalactosaminyltransferase 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT1 mRNA CTD PMID:19167446 NCBI chr18:24,205,321...24,286,816
Ensembl chr18:24,205,344...24,286,818
JBrowse link
G Galnt10 polypeptide N-acetylgalactosaminyltransferase 10 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT10 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of GALNT10 mRNA
Coumestrol results in decreased expression of GALNT10 mRNA
CTD PMID:19167446 NCBI chr11:57,645,442...57,787,514
Ensembl chr11:57,645,442...57,787,514
JBrowse link
G Galnt7 polypeptide N-acetylgalactosaminyltransferase 7 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT7 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of GALNT7 mRNA
Coumestrol results in decreased expression of GALNT7 mRNA
CTD PMID:19167446 NCBI chr 8:57,523,825...57,653,055
Ensembl chr 8:57,523,828...57,653,032
JBrowse link
G Ganab alpha glucosidase 2 alpha neutral subunit multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GANAB mRNA CTD PMID:19167446 NCBI chr19:8,898,057...8,916,742
Ensembl chr19:8,898,071...8,916,672
JBrowse link
G Gart phosphoribosylglycinamide formyltransferase increases expression ISO Coumestrol results in increased expression of GART mRNA CTD PMID:19167446 NCBI chr16:91,621,395...91,646,972
Ensembl chr16:91,621,186...91,646,952
JBrowse link
G Gas2l3 growth arrest-specific 2 like 3 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GAS2L3 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GAS2L3 mRNA CTD PMID:19167446 NCBI chr10:89,408,822...89,443,980
Ensembl chr10:89,408,823...89,443,967
JBrowse link
G Gata2 GATA binding protein 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GATA2 mRNA CTD PMID:19167446 NCBI chr 6:88,193,891...88,207,032
Ensembl chr 6:88,193,891...88,207,032
JBrowse link
G Gata3 GATA binding protein 3 decreases expression ISO Coumestrol results in decreased expression of GATA3 mRNA CTD PMID:19167446 NCBI chr 2:9,857,078...9,887,953
Ensembl chr 2:9,857,078...9,890,034
JBrowse link
G Gatad1 GATA zinc finger domain containing 1 decreases expression ISO Coumestrol results in decreased expression of GATAD1 mRNA CTD PMID:19167446 NCBI chr 5:3,639,961...3,647,936
Ensembl chr 5:3,632,932...3,657,185
JBrowse link
G Gbp2 guanylate binding protein 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GBP2 mRNA CTD PMID:19167446 NCBI chr 3:142,620,663...142,638,008
Ensembl chr 3:142,620,602...142,638,008
JBrowse link
G Gchfr GTP cyclohydrolase I feedback regulator multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GCHFR mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GCHFR mRNA
Coumestrol results in increased expression of GCHFR mRNA
CTD PMID:19167446 NCBI chr 2:119,167,788...119,172,389
Ensembl chr 2:119,167,773...119,172,390
JBrowse link
G Gclm glutamate-cysteine ligase, modifier subunit multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of GCLM mRNA CTD PMID:19167446 NCBI chr 3:122,245,487...122,267,215
Ensembl chr 3:122,245,557...122,270,732
JBrowse link
G Gdf15 growth differentiation factor 15 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GDF15 mRNA
Coumestrol results in decreased expression of GDF15 mRNA
CTD PMID:19167446 NCBI chr 8:70,629,393...70,632,470
Ensembl chr 8:70,629,393...70,632,456
JBrowse link
G Gdpd3 glycerophosphodiester phosphodiesterase domain containing 3 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GDPD3 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of GDPD3 mRNA
Coumestrol results in decreased expression of GDPD3 mRNA
CTD PMID:19167446 NCBI chr 7:126,766,414...126,775,645
Ensembl chr 7:126,766,334...126,775,649
JBrowse link
G Gem GTP binding protein (gene overexpressed in skeletal muscle) increases expression ISO Coumestrol results in increased expression of GEM mRNA CTD PMID:19167446 NCBI chr 4:11,704,447...11,714,993
Ensembl chr 4:11,704,457...11,714,752
JBrowse link
G Gemin2 gem nuclear organelle associated protein 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GEMIN2 mRNA
Coumestrol results in increased expression of GEMIN2 mRNA
CTD PMID:19167446 NCBI chr12:59,013,391...59,028,470
Ensembl chr12:59,013,393...59,028,470
JBrowse link
G Gemin4 gem nuclear organelle associated protein 4 increases expression ISO Coumestrol results in increased expression of GEMIN4 mRNA CTD PMID:19167446 NCBI chr11:76,210,571...76,217,572
Ensembl chr11:76,210,571...76,217,664
JBrowse link
G Gemin6 gem nuclear organelle associated protein 6 increases expression ISO Coumestrol results in increased expression of GEMIN6 mRNA CTD PMID:19167446 NCBI chr17:80,207,504...80,228,497
Ensembl chr17:80,224,441...80,228,497
JBrowse link
G Gfra1 glial cell line derived neurotrophic factor family receptor alpha 1 increases expression
multiple interactions
ISO Coumestrol results in increased expression of GFRA1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GFRA1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GFRA1 mRNA
CTD PMID:19167446 NCBI chr19:58,235,581...58,455,946
Ensembl chr19:58,235,604...58,455,909
JBrowse link
G Gga2 golgi associated, gamma adaptin ear containing, ARF binding protein 2 increases expression ISO Coumestrol results in increased expression of GGA2 mRNA CTD PMID:19167446 NCBI chr 7:121,986,722...122,021,198
Ensembl chr 7:121,986,722...122,021,222
JBrowse link
G Ggct gamma-glutamyl cyclotransferase multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GGCT mRNA CTD PMID:19167446 NCBI chr 6:54,985,095...54,992,960
Ensembl chr 6:54,982,580...54,992,950
JBrowse link
G Ggh gamma-glutamyl hydrolase multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GGH mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GGH mRNA
Coumestrol results in increased expression of GGH mRNA
CTD PMID:19167446 NCBI chr 4:20,041,997...20,066,111
Ensembl chr 4:20,042,052...20,066,750
JBrowse link
G Gins1 GINS complex subunit 1 (Psf1 homolog) multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GINS1 mRNA
Coumestrol results in increased expression of GINS1 mRNA
CTD PMID:19167446 NCBI chr 2:150,909,556...150,931,280
Ensembl chr 2:150,905,400...150,931,280
JBrowse link
G Gins2 GINS complex subunit 2 (Psf2 homolog) multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GINS2 mRNA
Coumestrol results in increased expression of GINS2 mRNA
CTD PMID:19167446 NCBI chr 8:120,581,266...120,589,075
Ensembl chr 8:120,578,633...120,589,304
JBrowse link
G Gins3 GINS complex subunit 3 (Psf3 homolog) multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS3 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GINS3 mRNA
Coumestrol results in increased expression of GINS3 mRNA
CTD PMID:19167446 NCBI chr 8:95,633,559...95,645,059
Ensembl chr 8:95,633,453...95,645,060
JBrowse link
G Gins4 GINS complex subunit 4 (Sld5 homolog) multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS4 mRNA CTD PMID:19167446 NCBI chr 8:23,226,610...23,237,668
Ensembl chr 8:23,226,616...23,237,659
JBrowse link
G Gla galactosidase, alpha multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of GLA mRNA
Coumestrol results in increased expression of GLA mRNA
CTD PMID:19167446 NCBI chr  X:134,588,169...134,601,005
Ensembl chr  X:134,588,149...134,601,125
JBrowse link
G Gle1 GLE1 RNA export mediator (yeast) increases expression
multiple interactions
ISO Coumestrol results in increased expression of GLE1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GLE1 mRNA
CTD PMID:19167446 NCBI chr 2:29,935,409...29,959,432
Ensembl chr 2:29,935,426...29,960,371
JBrowse link
G Glmn glomulin, FKBP associated protein increases expression ISO Coumestrol results in increased expression of GLMN mRNA CTD PMID:19167446 NCBI chr 5:107,548,962...107,597,888
Ensembl chr 5:107,548,967...107,597,888
JBrowse link
G Glmp glycosylated lysosomal membrane protein multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of GLMP mRNA CTD PMID:19167446 NCBI chr 3:88,325,023...88,328,631
Ensembl chr 3:88,325,023...88,331,313
JBrowse link
G Gls glutaminase decreases expression ISO Coumestrol results in decreased expression of GLS mRNA CTD PMID:19167446 NCBI chr 1:52,163,449...52,235,009
Ensembl chr 1:52,163,448...52,233,232
JBrowse link
G Gmnn geminin multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GMNN mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GMNN mRNA
Coumestrol results in increased expression of GMNN mRNA
CTD PMID:19167446 NCBI chr13:24,751,845...24,761,937
Ensembl chr13:24,751,845...24,761,923
JBrowse link
G Gmps guanine monophosphate synthetase multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GMPS mRNA CTD PMID:19167446 NCBI chr 3:63,963,633...64,021,554
Ensembl chr 3:63,976,106...64,022,579
JBrowse link
G Gnai1 guanine nucleotide binding protein (G protein), alpha inhibiting 1 decreases expression ISO Coumestrol results in decreased expression of GNAI1 mRNA CTD PMID:19167446 NCBI chr 5:18,265,135...18,360,413
Ensembl chr 5:18,265,135...18,360,355
JBrowse link
G Gnaq guanine nucleotide binding protein, alpha q polypeptide decreases expression ISO Coumestrol results in decreased expression of GNAQ mRNA CTD PMID:19167446 NCBI chr19:16,132,684...16,388,520
Ensembl chr19:16,132,831...16,387,463
JBrowse link
G Gnl3l guanine nucleotide binding protein-like 3 (nucleolar)-like decreases expression ISO Coumestrol results in decreased expression of GNL3L mRNA CTD PMID:19167446 NCBI chr  X:150,983,133...151,017,322
Ensembl chr  X:150,983,141...151,017,322
JBrowse link
G Gns glucosamine (N-acetyl)-6-sulfatase decreases expression ISO Coumestrol results in decreased expression of GNS mRNA CTD PMID:19167446 NCBI chr10:121,365,090...121,397,254
Ensembl chr10:121,365,090...121,397,249
JBrowse link
G Golga2 golgi autoantigen, golgin subfamily a, 2 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of GOLGA2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GOLGA2 mRNA
CTD PMID:19167446 NCBI chr 2:32,288,287...32,307,913
Ensembl chr 2:32,287,384...32,307,921
JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1, soluble increases expression
multiple interactions
ISO Coumestrol results in increased expression of GOT1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GOT1 mRNA
CTD PMID:19167446 NCBI chr19:43,499,752...43,524,605
Ensembl chr19:43,499,752...43,524,605
JBrowse link
G Gpaa1 GPI anchor attachment protein 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPAA1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GPAA1 mRNA CTD PMID:19167446 NCBI chr15:76,331,294...76,334,900
Ensembl chr15:76,331,231...76,334,907
JBrowse link
G Gpat4 glycerol-3-phosphate acyltransferase 4 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPAT4 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GPAT4 mRNA CTD PMID:19167446 NCBI chr 8:23,171,265...23,208,453
Ensembl chr 8:23,171,265...23,208,346
JBrowse link
G Gpatch11 G patch domain containing 11 increases expression ISO Coumestrol results in increased expression of GPATCH11 mRNA CTD PMID:19167446 NCBI chr17:78,835,516...78,848,308
Ensembl chr17:78,835,567...78,848,308
JBrowse link
G Gpatch2l G patch domain containing 2 like decreases expression ISO Coumestrol results in decreased expression of GPATCH2L mRNA CTD PMID:19167446 NCBI chr12:86,241,795...86,294,657
Ensembl chr12:86,241,858...86,291,784
JBrowse link
G Gpatch4 G patch domain containing 4 increases expression ISO Coumestrol results in increased expression of GPATCH4 mRNA CTD PMID:19167446 NCBI chr 3:88,043,106...88,055,994
Ensembl chr 3:88,043,108...88,055,993
JBrowse link
G Gpd2 glycerol phosphate dehydrogenase 2, mitochondrial increases expression ISO Coumestrol results in increased expression of GPD2 mRNA CTD PMID:19167446 NCBI chr 2:57,237,678...57,370,719
Ensembl chr 2:57,237,635...57,370,719
JBrowse link
G Gper1 G protein-coupled estrogen receptor 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of GPER1 mRNA CTD PMID:19167446 NCBI chr 5:139,423,150...139,427,800
Ensembl chr 5:139,423,151...139,427,800
JBrowse link
G Gpr137b G protein-coupled receptor 137B decreases expression ISO Coumestrol results in decreased expression of GPR137B mRNA CTD PMID:19167446 NCBI chr13:13,357,620...13,393,644
Ensembl chr13:13,357,620...13,394,014
JBrowse link
G Gpr160 G protein-coupled receptor 160 decreases expression ISO Coumestrol results in decreased expression of GPR160 mRNA CTD PMID:19167446 NCBI chr 3:30,855,759...30,897,194
Ensembl chr 3:30,855,950...30,897,192
JBrowse link
G Gprc5a G protein-coupled receptor, family C, group 5, member A multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GPRC5A mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of GPRC5A mRNA
Coumestrol results in decreased expression of GPRC5A mRNA
CTD PMID:19167446 NCBI chr 6:135,065,662...135,084,709
Ensembl chr 6:135,065,651...135,084,709
JBrowse link
G Gprc5c G protein-coupled receptor, family C, group 5, member C decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of GPRC5C mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GPRC5C mRNA
CTD PMID:19167446 NCBI chr11:114,851,150...114,872,617
Ensembl chr11:114,851,152...114,872,617
JBrowse link
G Gpsm2 G-protein signalling modulator 2 (AGS3-like, C. elegans) multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPSM2 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of GPSM2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GPSM2 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of GPSM2 mRNA]
Coumestrol results in increased expression of GPSM2 mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr 3:108,678,270...108,722,331
Ensembl chr 3:108,678,638...108,722,309
JBrowse link
G Gpx8 glutathione peroxidase 8 (putative) increases expression
multiple interactions
ISO Coumestrol results in increased expression of GPX8 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of GPX8 mRNA
CTD PMID:19167446 NCBI chr13:113,042,757...113,046,430
Ensembl chr13:113,042,753...113,046,410
JBrowse link
G Gramd1a GRAM domain containing 1A multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GRAMD1A mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of GRAMD1A mRNA CTD PMID:19167446 NCBI chr 7:31,130,127...31,155,935
Ensembl chr 7:31,130,127...31,155,896
JBrowse link
G Grb10 growth factor receptor bound protein 10 decreases expression ISO Coumestrol results in decreased expression of GRB10 mRNA CTD PMID:19167446 NCBI chr11:11,930,499...12,037,428
Ensembl chr11:11,930,508...12,038,683
JBrowse link
G Greb1 gene regulated by estrogen in breast cancer protein multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GREB1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of GREB1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GREB1 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of GREB1 mRNA]
Coumestrol results in increased expression of GREB1 mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr12:16,670,615...16,801,394
Ensembl chr12:16,670,615...16,800,886
JBrowse link
G Grhl3 grainyhead like transcription factor 3 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GRHL3 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of GRHL3 mRNA CTD PMID:19167446 NCBI chr 4:135,541,887...135,573,632
Ensembl chr 4:135,541,888...135,573,630
JBrowse link
G Grk6 G protein-coupled receptor kinase 6 increases expression ISO Coumestrol results in increased expression of GRK6 mRNA CTD PMID:19167446 NCBI chr13:55,445,072...55,460,927
Ensembl chr13:55,445,072...55,460,927
JBrowse link
G Grn granulin multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of GRN mRNA CTD PMID:19167446 NCBI chr11:102,430,507...102,436,809
Ensembl chr11:102,430,315...102,437,048
JBrowse link
G Grpel1 GrpE-like 1, mitochondrial increases expression ISO Coumestrol results in increased expression of GRPEL1 mRNA CTD PMID:19167446 NCBI chr 5:36,465,185...36,474,077
Ensembl chr 5:36,464,998...36,474,080
JBrowse link
G Gtf2h4 general transcription factor II H, polypeptide 4 increases expression ISO Coumestrol results in increased expression of GTF2H4 mRNA CTD PMID:19167446 NCBI chr17:35,667,728...35,673,750
Ensembl chr17:35,667,730...35,673,739
JBrowse link
G Gtf2ird1 general transcription factor II I repeat domain-containing 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GTF2IRD1 mRNA CTD PMID:19167446 NCBI chr 5:134,357,661...134,456,867
Ensembl chr 5:134,357,656...134,456,716
JBrowse link
G Gtse1 G two S phase expressed protein 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GTSE1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of GTSE1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GTSE1 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of GTSE1 mRNA]
Coumestrol results in increased expression of GTSE1 mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr15:85,859,691...85,876,573
Ensembl chr15:85,859,745...85,876,573
JBrowse link
G Gulp1 GULP, engulfment adaptor PTB domain containing 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GULP1 mRNA
Coumestrol results in decreased expression of GULP1 mRNA
CTD PMID:19167446 NCBI chr 1:44,551,380...44,796,838
Ensembl chr 1:44,551,511...44,796,838
JBrowse link
G H1f2 H1.2 linker histone, cluster member decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of H1-2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of H1-2 mRNA
CTD PMID:19167446 NCBI chr13:23,738,807...23,739,531
Ensembl chr13:23,738,808...23,740,367
JBrowse link
G H2-Ke6 H2-K region expressed gene 6 increases expression ISO Coumestrol results in increased expression of HSD17B8 mRNA CTD PMID:19167446 NCBI chr17:34,026,033...34,028,055
Ensembl chr17:34,026,033...34,028,060
JBrowse link
G H2ac22 H2A clustered histone 22 decreases expression ISO Coumestrol results in decreased expression of H2AC11 mRNA CTD PMID:19167446 NCBI chr13:21,786,774...21,787,248
Ensembl chr13:21,786,826...21,787,218
JBrowse link
G H2ac6 H2A clustered histone 6 decreases expression ISO Coumestrol results in decreased expression of H2AC15 mRNA CTD PMID:19167446 NCBI chr13:23,683,473...23,683,959
Ensembl chr13:23,681,467...23,683,948
JBrowse link
G H2ac8 H2A clustered histone 8 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of H2AC8 mRNA
Coumestrol results in decreased expression of H2AC8 mRNA
CTD PMID:19167446 NCBI chr13:23,570,663...23,571,220
Ensembl chr13:23,570,517...23,571,220
JBrowse link
G H2aw H2A.W histone multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of H2AW mRNA CTD